Rochkind v. Stevenson , 471 Md. 1 ( 2020 )

Stanley Rochkind v. Starlena Stevenson, No. 47, September Term, 2019. Opinion by
Getty, J.
EXPERT WITNESS TESTIMONY—MARYLAND RULE 5-702—SUFFICIENT
FACTUAL BASIS—FRYE-REED STANDARD—DAUBERT STANDARD
Over four decades ago, the Court of Appeals in Reed v. State, 283 Md. 374 (1978), adopted
the “general acceptance” test—first espoused in Frye v. United States, 293 F. 1013 (D.C.
Cir. 1923)—for the admissibility of expert testimony based on new or novel scientific
principles. In 1993, the Supreme Court of the United States, in adopting a new “reliability”
standard for admissibility of expert testimony in federal courts, endorsed a nonexclusive
list of reliability factors. Daubert v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579(1993). In that case, the Supreme Court held that Federal Rule of Evidence (“FRE”) 702
superseded Frye. The following year, the Court of Appeals adopted Maryland Rule 5-702,
a rule modeled after FRE 702, which laid out the elements of admissible expert testimony.
Maryland Rule 5-702, however, did not overrule Reed or Frye. Since 1994, the relationship
between Frye-Reed and Maryland Rule 5-702 has complicated.
The Court of Appeals adopted the Daubert reliability factors, overruling Frye and Reed.
When interpreting Maryland Rule 5-702, Maryland courts, instead of merely looking to the
general acceptance in the relevant scientific community, should consider, but are not
limited to: (1) whether a theory or technique can be (and has been) tested; (2) whether a
theory or technique has been subjected to peer review and publication; (3) whether a
particular scientific technique has a known or potential rate of error; (4) the existence and
maintenance of standards and controls; (5) whether a theory or technique is generally
accepted; (6) whether experts are proposing to testify about matters growing naturally and
directly out of research they have conducted independent of the litigation, or whether they
have developed their opinions expressly for purposes of testifying; (7) whether the expert
has unjustifiably extrapolated from an accepted premise to an unfounded conclusion; (8)
whether the expert has adequately accounted for obvious alternative explanations; (9)
whether the expert is being as careful as he or she would be in his or her regular
professional work outside his or her paid litigation consulting; and (10) whether the field
of expertise claimed by the expert is known to reach reliable results for the type of opinion
the expert would give.
Circuit Court for Baltimore City
Case No. 24-C-11-008722
Argued: February 7, 2020
IN THE COURT OF APPEALS
OF MARYLAND
No. 47
September Term, 2019
STANLEY ROCHKIND
v.
STARLENA STEVENSON
McDonald,
Watts,
Hotten,
Getty,
Booth,
Biran,
Greene, Clayton Jr. (Senior Judge,
Specially Assigned),
JJ.
Opinion by Getty, J.
Watts, Hotten, and Greene, JJ., dissent.
Pursuant to Maryland Uniform Electronic Legal Materials Act
(§§ 10-1601 et seq. of the State Government Article) this document
is authentic. Filed: August 28, 2020
Suzanne Johnson
2020-08-28 10:47-04:00
Suzanne C. Johnson, Clerk
Nearly a century ago, the United States Court of Appeals for the District of
Columbia announced a new evidentiary standard by which the admissibility of expert
testimony rooted in a novel scientific principle or discovery turned on the “general
acceptance” of such evidence “in the particular field in which it belongs.” Frye v. United
States, 293 F. 1013, 1014 (D.C. Cir. 1923). In the ensuing fifty years, “almost all of the
courts in the country” that considered “the admissibility of scientific evidence” adopted the
rationale set out in Frye, including this Court in 1978. Reed v. State, 283 Md. 374, 382
(1978). Hence, after noting the majority of courts were in agreement that “‘general
acceptance’ in the [relevant] scientific community ha[d] come to be the standard,” Frye-
Reed was born in Maryland; as we put it, “before a scientific opinion will be received as
evidence at trial, the basis of that opinion must be shown to be generally accepted as
reliable within the expert’s” relevant scientific community. Id. at 381.
In Daubert v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), the
Supreme Court of the United States upset the applecart of the admissibility of expert
scientific testimony. There, the Supreme Court held that Federal Rule of Evidence (“FRE”)
702 superseded Frye’s general acceptance test. In place of Frye, the Supreme Court
provided a list of flexible factors to help courts determine the reliability of expert
testimony. A supermajority of states followed the Supreme Court’s lead and replaced their
respective Frye standards with Daubert. Maryland, however, did not.
In the forty years that followed Reed, Maryland experienced a jurisprudential drift:
the Frye-Reed standard announced in 1978 slowly morphed into a “Frye-Reed Plus”
standard, implicitly and explicitly relying on and adopting several Daubert principles. For
this reason, Appellant/Cross-Petitioner Stanley Rochkind now squarely poses this
question: Should the Court adopt the standard for admitting expert testimony under
Daubert v. Merrell Dow Pharmaceuticals, Inc.? This time, for reasons more fully
explained below, we answer this question in the affirmative and choose to adopt Daubert
as the governing standard by which trial courts admit or exclude expert testimony.
BACKGROUND
A. Ms. Stevenson’s Lead Paint Exposure and Medical History.1
In 1991, a 10-month-old Starlena Stevenson and her mother, Charlena Montgomery,
moved to 3823 Fairview Avenue (“Fairview”), where they lived for 15 months. At the
time, Fairview was owned in part by Mr. Rochkind. According to Ms. Montgomery,
Fairview contained chipping and flaking paint on the windowsills, floors, and front porch.
Blood lead level tests taken while Ms. Stevenson was a resident of Fairview revealed that
she had a blood lead level of 13 to 14 micrograms per deciliter—a number that dropped to
11 micrograms per deciliter just two months later when she was no longer a resident of that
property.
Ms. Stevenson, now 29 years old, has a family history of learning disabilities and
has faced numerous medical, psychological, and socioeconomic obstacles. She was born
to a single teenage mother and has no relationship with her father. As a child, she was
diagnosed with Attention Deficit Hyperactivity Disorder, commonly referred to as ADHD,
1
For a comprehensive background to this case, refer to the Court’s opinion in Rochkind
v. Stevenson, 454 Md. 277, 281–84 (2017) (“Stevenson I”).
2
and several major psychological disorders including oppositional defiance disorder, major
depressive disorder, anxiety disorder, and parent-child relationship disorder. Her
psychological problems were so severe that in 2004 she engaged in self-mutilation and
attempted suicide.
Since graduating from high school in 2008, Ms. Stevenson has been sporadically
employed, working as a patient transporter for the University of Maryland Medical System,
a cashier for Royal Farms, and a babysitter. In each case, Ms. Stevenson struggled to stay
employed due to her attentional deficits, hyperactivity, and impulsivity—symptoms which
she claims resulted from her exposure to lead paint.
B. The First and Second Trials.
In December 2011, Ms. Stevenson filed suit against Mr. Rochkind in the Circuit
Court for Baltimore City for negligence and violations of the Maryland Consumer
Protection Act. In July 2012, lead testing conducted at Fairview detected lead-based paint
on twenty-two interior surfaces and nine exterior surfaces. In preparation for the litigation,
Cecilia Hall-Carrington, M.D., a pediatrician, filed a report concluding to “a reasonable
degree of medical probability” that Ms. Stevenson was poisoned by lead at Fairview, and
that “her lead poisoning is a significant contributing factor” to her neuropsychological
problems, including her ADHD.
Before trial, Mr. Rochkind filed four motions in limine seeking to exclude Dr. Hall-
Carrington’s testimony. He argued that she should not be permitted to testify that Fairview
was a source of Ms. Stevenson’s lead exposure or that such exposure caused Ms.
Stevenson’s “cognitive deficits,” including, specifically, ADHD. Mr. Rochkind requested
3
a Frye-Reed hearing on each motion. The court denied his requests. After hearing
arguments on the motions in limine, the court denied them as well. The jury returned a
verdict in favor of Ms. Stevenson, awarding her $829,000 in economic damages and
$534,000 in noneconomic damages. Mr. Rochkind filed a motion for a new trial, or, in the
alternative, remittitur. The court granted his motion in part and ordered a new trial on the
issue of damages alone.
The partial new trial began in October 2014. Before trial, Mr. Rochkind renewed
his motions in limine to exclude Dr. Hall-Carrington’s ADHD testimony, which were again
denied. The court declined to hold a Frye-Reed hearing, explaining that Dr. Hall-
Carrington’s opinions are “not new science” or “new conclusions.” It admitted her
testimony under Maryland Rule 5-702 because it found that she drew from “reliable
sources.”
At trial, Dr. Hall-Carrington testified as to both general and specific ADHD
causation. She explained that studies show that lead exposure can cause “attention
problems[] or ADHD” generally. She also opined “within a reasonable degree of medical
probability” that lead exposure caused Ms. Stevenson’s ADHD specifically. To support
her testimony, Dr. Hall-Carrington relied on a publication from the Environmental
Protection Agency reviewing the most recent studies on the effects of lead exposure in
children, titled “Integrated Science Assessment for Lead” (the “EPA-ISA”).2 She testified
2
U.S. Envtl. Prot. Agency, EPA/600/R–10/075F, Integrated Science Assessment for Lead
(2013), https://www.epa.gov/isa/integrated-science-assessment-isa-lead (follow “PDF”
hyperlink), archived at https://perma.cc/K28Z-F58P.
4
that the EPA-ISA concluded that there is a causal relationship between lead exposure and
the symptoms of ADHD, such as attention decrements, impulsivity, and hyperactivity. Dr.
Hall-Carrington also testified that “some years ago there was a concern with suicide in kids
[taking] Adderall.” In closing argument, Ms. Stevenson’s counsel implied that Ms.
Stevenson’s depression and hallucinations were side effects of her ADHD medications,
including Adderall.
The jury awarded Ms. Stevenson $753,000 in economic damages and $700,000 in
noneconomic damages. Due to the statutory cap on noneconomic damages, the court
reduced the total judgment to $1,103,000. Mr. Rochkind filed a motion for a new trial,
which the court denied.
On appeal, the Court of Special Appeals held, among other things, that the circuit
court did not err in failing to hold a Frye-Reed hearing on Dr. Hall-Carrington’s general
causation testimony because the studies she relied upon did not reach novel conclusions
and “used methodologies that are generally accepted” in the scientific community.
Rochkind v. Stevenson, 229 Md. App. 422, 464 (2016). The intermediate appellate court
also held that the circuit court properly admitted Dr. Hall-Carrington’s specific causation
testimony under Rule 5-702 because her opinion “was supported by an adequate factual
basis and was sufficient to allow the jury to decide the causal connection, if any, between
lead exposure and Ms. Stevenson’s ADHD.” Id. at 465. Mr. Rochkind appealed.
C. Stevenson I.
In his first appeal to this Court, Mr. Rochkind argued that Dr. Hall-Carrington’s
testimony should have been excluded because it failed to meet the requirements of both
5
Rule 5-702 and Frye-Reed. Rochkind v. Stevenson, 454 Md. 277, 285 (2017) (“Stevenson
I”). The Court agreed. Applying a Rule 5-702 analysis, the Court held that “Dr. Hall-
Carrington did not provide a sufficient factual foundation for why she thought the EPA-
ISA supported her conclusion that lead exposure can cause ADHD.” Id. at 290. The Court
concluded that because “Dr. Hall-Carrington did not cite to any other studies to support her
opinion that lead exposure can cause ADHD,” she “cannot be permitted to testify that such
a causal connection exists generally, or that lead exposure caused [Ms.] Stevenson’s
ADHD specifically.” Id. at 293–94 (footnote omitted). In light of its Rule 5-702
conclusion, the Court declined to address Mr. Rochkind’s argument that the circuit court
should have held a Frye-Reed hearing on Dr. Hall-Carrington’s general causation
testimony. Id. at 295. Because the Court found that the circuit court abused its discretion
in permitting Dr. Hall-Carrington to opine on the effects of lead exposure based on the
EPA-ISA, the Court remanded the case to the circuit court for a new trial on the issue of
damages. Id. at 295–96.
D. The Third and Fourth Trials.
Before the third trial, Mr. Rochkind filed a motion, once again attempting to exclude
Dr. Hall-Carrington’s specific causation opinions. The circuit court denied the motion and
request for a pre-trial Rule 5-702 and/or Frye-Reed hearing based on its reading of the
opinion in Stevenson I. According to the circuit court, so long as Dr. Hall-Carrington did
not actually use the word “ADHD,” she could opine that Ms. Stevenson’s attentional
6
deficits, hyperactivity, and impulsivity problems were caused by lead exposure. 3 Despite
the ruling, Dr. Hall-Carrington testified that lead exposure can cause “ADHD,” causing the
circuit court to declare a mistrial.
Not to be deterred, in trial number four, Dr. Hall-Carrington testified that lead
exposure caused Ms. Stevenson’s attentional deficits, hyperactivity, and impulsivity
problems, once again relying solely on the epidemiological studies cited in the EPA-ISA.
This time, however, Dr. Hall-Carrington did not mention “ADHD,” specifically. The jury
awarded Ms. Stevenson $1 million in economic damages and $2 million in non-economic
damages.
E. Post-Trial Motions and Appeal.
Mr. Rochkind filed a Motion for New Trial, Judgment Notwithstanding the Verdict
(“JNOV”), and Remittitur. The circuit court denied Mr. Rochkind’s motion for a new trial
and JNOV but reduced damages pursuant to the statutory cap. Mr. Rochkind appealed to
the Court of Special Appeals. While that appeal was pending, Ms. Stevenson filed a
Petition for Writ of Certiorari and Mr. Rochkind filed a Cross-Petition. We granted both
petitions to answer the following questions:
(1) Should the Court adopt the standard for admitting expert testimony under
Daubert v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993)?
(2) Was [Ms. Stevenson’s] medical causation expert’s specific causation
opinion admissible in this case under Rule 5-702, applying the standard set
forth in Daubert?
3
Mr. Rochkind submitted additional briefing and a formal offer of proof to preserve the
issue for appeal.
7
(3) Was it error for the trial court to allow [Ms. Stevenson’s] medical
causation expert to testify that [Ms. Stevenson] has attentional and behavioral
injuries without providing a reliable method for attributing those injuries to
lead exposure when [Ms. Stevenson] had already been diagnosed with
ADHD?
(4) Was it error for the trial court to allow [Ms. Stevenson’s] medical expert
to render specific causation opinions based on general epidemiological
studies?
STANDARD OF REVIEW
“[T]he admissibility of expert testimony is a matter largely within the discretion of
the trial court, and its action in admitting or excluding such testimony will seldom
constitute ground for reversal.” Roy v. Dackman, 445 Md. 23, 38–39 (2015). When the
basis of an expert’s opinion is challenged pursuant to Maryland Rule 5-702, the review is
abuse of discretion. Blackwell v. Wyeth, 408 Md. 575, 618 (2009). “Such a ruling,
however, may be reversed on appeal if it is founded on an error of law or some serious
mistake, or if the trial court clearly abused its discretion.” Sippio v. State, 350 Md. 633,
648 (1998) (citation and internal quotation marks omitted). Additionally, we will not
affirm a decision within the discretion of the trial court if the judge acts in an “arbitrary or
capricious manner” or “beyond the letter or reason of the law.” Garg v. Garg, 393 Md.
225, 238 (2006) (citation omitted).
DISCUSSION
A. Parties’ Contentions.
In Stevenson I, we held that it was error to allow Dr. Hall-Carrington to testify that
lead exposure generally causes ADHD and therefore error to testify that lead exposure
specifically caused Ms. Stevenson’s ADHD. 454 Md. at 293–96. On remand, the circuit
8
court ruled that Dr. Hall-Carrington was allowed to testify that Ms. Stevenson’s attentional
deficits, hyperactivity, and impulsivity—some of the symptoms of ADHD—were
specifically caused by lead exposure as long as she did not use the term “ADHD.” The
circuit court did not base its ruling on Rule 5-702 or Frye-Reed. It based its ruling solely
on its reading of this Court’s opinion in Stevenson I.
As Appellant/Cross-Petitioner, Mr. Rochkind initially argues that the Court should
adopt the Daubert standard, apply it to this case, and find that Dr. Hall-Carrington’s
specific causation opinion is inadmissible under Rule 5-702. Ms. Stevenson responds that
the Court should not adopt Daubert but that even under Daubert, Dr. Hall-Carrington’s
specific causation opinion would be admissible. Understandably, Mr. Rochkind, in support
of Daubert, and Ms. Stevenson, in opposition, each list a host of pros and cons to adopting
Daubert.
As Appellee/Petitioner, Ms. Stevenson argues that under current expert
admissibility jurisprudence, it was not error for the circuit court to allow Dr. Hall-
Carrington to testify that Ms. Stevenson has a physical brain injury attributable to lead
exposure that manifested in symptoms of attentional deficits, hyperactivity and
impulsivity. To support this position, Ms. Stevenson maintains that Dr. Hall-Carrington
provided a reliable methodology consistent with Maryland tort law’s “substantial factor”
causation standard. Ms. Stevenson lastly argues that the circuit court did not err in allowing
specific causation opinions based on general epidemiological studies.
Mr. Rochkind responds that even under Frye-Reed, it was error for the circuit court
to allow Dr. Hall-Carrington to testify that Ms. Stevenson’s attentional and behavioral
9
problems were caused by lead exposure because (1) Ms. Stevenson had been clinically
diagnosed with ADHD and (2) Dr. Hall-Carrington did not have a reliable methodology
for attributing those problems to lead exposure as opposed to ADHD. Mr. Rochkind
further asserts that it was error for Dr. Hall-Carrington to opine that lead exposure caused
Ms. Stevenson’s attentional deficits, hyperactivity, and impulsivity problems based on a
document that states it cannot be applied to individuals. In essence, these are the same
arguments that Mr. Rochkind brought in Stevenson I, this time in the context of attentional
deficits, hyperactivity, and impulsivity as opposed to “ADHD,” specifically.
In the lead up to the Daubert debate, we begin with the legal background.
B. Legal Background: Frye-Reed and Maryland Rule 5-702.
Maryland courts admit expert testimony through two channels—the Frye-Reed
standard and Maryland Rule 5-702. Nominally, the relationship between the channels is
simple: to be admissible, expert testimony discussing novel scientific theories must meet
both the minimum threshold Frye-Reed standard and the Rule 5-702 requirements, but
expert testimony addressing non-novel scientific evidence must only meet the requirements
of Rule 5-702. Often, however, the relationship between the tests is not so simple. For
example, what test (or tests) applies when “the underlying data and methods for gathering
this data are generally accepted in the scientific community but applied to support a novel
theory[?]” Blackwell, 408 Md. at 596.
Despite decades of jurisprudence on the topic, the Frye-Reed standard—and its
relationship to Maryland Rule 5-702—holds a confusing grip on Maryland bench and bar.
What was originally set out in 1978 as a simple test for admissibility has become
10
increasingly complex with the development of Daubert case law. We begin by chronicling
the Frye-Reed “greatest hits.”
1. From Frye to Daubert.
In Reed v. State, 283 Md. 374 (1978), this Court, like most state appellate courts to
consider the issue,4 adopted the “general acceptance” test first espoused in Frye v. United
States, 293 F. 1013 (D.C. Cir. 1923): for expert testimony predicated on a novel scientific
principle or discovery to be admissible, the scientific principles or discoveries must be
generally accepted in the relevant scientific community. For decades thereafter, Maryland
appellate courts applied Frye-Reed only in novel scientific evidence cases. See, e.g., Kelley
v. State, 288 Md. 298, 302 (1980) (polygraph); State v. Collins, 296 Md. 670, 678–79
(1983) (hypnosis); U.S. Gypsum Co. v. Mayor & City Council of Balt., 336 Md. 145, 182–
83 (1994) (surface dust sampling in asbestos cases); Schultz v. State, 106 Md. App. 145,
150–57 (1995) (horizontal gaze nystagmus field sobriety tests); Keene Corp., Inc. v. Hall,
96 Md. App. 644, 652–60 (1993) (polarized light microscopy in asbestos cases).
Meanwhile, seventy years after Frye, the Supreme Court of the United States
adopted a new standard for admissibility of expert testimony in federal courts. In Daubert
v. Merrell Dow Pharmaceuticals, Inc., the Supreme Court held that FRE 702 superseded
Frye. 509 U.S. 579 (1993). At the time, FRE 702 provided that “a witness qualified as an
expert by knowledge, skill, experience, training, or education, may testify . . . in the form
of an opinion or otherwise” about “scientific, technical, or other specialized knowledge
4
See Reed v. State, 283 Md. 374, 382 (1978) (collecting cases).
11
[that] will assist the trier of fact to understand the evidence or to determine a fact in issue.”
The Supreme Court read FRE 702 to mandate a threshold determination as to whether the
“scientific testimony” at issue is “not only relevant, but reliable.” Id. at 589. On reliability,
the Supreme Court provided a non-exclusive list of factors that may be pertinent: (1)
“whether a theory or technique . . . can be (and has been) tested”; (2) “whether [it] has been
subjected to peer review and publication”; (3) “the known or potential rate of error”; (4)
“the existence and maintenance of standards controlling the technique’s operation”; and—
harkening back to Frye—(5) whether it is “general[ly] accepted” within the relevant
scientific community. Id. at 593–94. The Daubert analysis, according to the Supreme
Court, was more flexible than the “uncompromising [Frye] ‘general acceptance’ test” and
gave trial courts greater discretion to admit scientific expert testimony that is relevant and
founded on sound principles, even though novel or controversial. Id. at 596.
Four years later, in General Electric Co. v. Joiner, the Supreme Court scrutinized
epidemiological studies regarding a cause of lung cancer. 522 U.S. 136, 145–46 (1997).
The Joiner Court held that because none of the studies provided a causal link between the
chlorine compound and lung cancer, “there is simply too great an analytical gap between
the data and the opinion proffered.” Id. at 146. The studies therefore did not support the
expert testimony in that case. Joiner and the “analytical gap” analysis, as discussed below,
is now a critical piece of Maryland’s Frye-Reed analysis. To complete the “Daubert
12
trilogy,”5 the Supreme Court held in Kumho Tire Co. v. Carmichael, that “Daubert’s
general holding . . . applies not only to testimony based on ‘scientific’ knowledge, but also
to testimony based on ‘technical’ and ‘other specialized’ knowledge.” 526 U.S. 137, 141
(1999).6
A supermajority of jurisdictions have departed from Frye in favor of the flexible
Daubert approach.7 Maryland stands strong amongst the minority jurisdictions that adhere
to Frye or a modified Frye test.8 Maryland’s Frye-Reed standard, as it currently stands, is
5
See, e.g., Motorola Inc. v. Murray, 147 A.3d 751, 753–56 (D.C. 2016) (describing—as
others have before it—Daubert, Joiner, and Kumho Tire, as the “Daubert Trilogy”).
6
In 2000, the FRE were amended (in response to Daubert and its progeny, see Fed. R.
Evid. 702 advisory committee’s note) to include language requiring expert testimony to be
based on “sufficient facts or data.” The FRE were restyled in 2011 without substantive
changes. FRE 702 now reads:
A witness who is qualified as an expert by knowledge, skill, experience,
training, or education may testify in the form of an opinion or otherwise if:
(a) the expert’s scientific, technical, or other specialized knowledge will help
the trier of fact to understand the evidence or to determine a fact in issue;
(b) the testimony is based on sufficient facts or data;
(c) the testimony is the product of reliable principles and methods; and
(d) the expert has reliably applied the principles and methods to the facts of
the case.
7
See Savage v. State, 455 Md. 138, 178 n.3 (2017) (Adkins, J., concurring) (listing 38
jurisdictions that “have either explicitly adopted Daubert or held that its factors are
persuasive in evaluating expert witness testimony”). One additional state, Florida, adopted
Daubert by court order in 2019. In re: Amendments to Fla. Evidence Code, 278 So.3d 551(Fla. 2019).
8
See id. at 179 n.4 (listing jurisdictions that apply a traditional or modified Frye analysis).
13
broader than it used to be. Some Maryland courts have suggested that Frye-Reed has
“drift[ed]” toward Daubert in two ways: first, that courts have used Frye-Reed “not only
to evaluate scientific methods, but also to assess scientific conclusions”; and second, that
courts have applied Frye-Reed to established, as well as novel, scientific methods. Savage
v. State, 455 Md. 138, 180–81 (2017) (Adkins, J., concurring); see Burks v. Allen, 238 Md.
App. 418, 454–59 (2018); Sissoko v. State, 236 Md. App. 676, 708–09 (2018).
2. The First “Drift”: Scientific Conclusions.
This Court has modified the reach of Frye-Reed to include not only scientific
methods, but also scientific conclusions. First indicated in Wilson v. State, 370 Md. 191(2002) (holding that an expert’s conclusion that SIDS deaths in a single family are
genetically related was inadmissible even when based on a reliable statistical method—the
“product rule”—because there was not general agreement in the medical community for
such a conclusion), the Court expanded Frye-Reed in a trio of cases. Montgomery Mut.
Ins. Co. v. Chesson, 399 Md. 314 (2007) (“Chesson I”); Blackwell, 408 Md. at 575;
Chesson v. Montgomery Mut. Ins. Co., 434 Md. 346 (2013) (“Chesson II”).
In Chesson I, the Court analyzed the admissibility of an expert medical opinion that
exposure to mold causes “sick building syndrome.” 399 Md. at 317. Petitioners argued
that the circuit court erred when it refused to hold a Frye-Reed hearing on the admissibility
of the expert testimony. Respondents countered that expert opinions concerning the cause
or origin of a person’s condition are not subject to Frye-Reed. In essence, because the
14
methods of the expert were not novel, respondents believed that a Frye-Reed analysis was
unnecessary. We disagreed, noting
that in cases in which the proper choice of [scientific] techniques was
dependent on an underlying scientific phenomenon or principle, a court must
engage in Frye-Reed analysis to determine whether that phenomenon or
principle is generally accepted in the scientific community and whether the
proper scientific tests were used to reach the expert’s conclusions.
Id. at 329–30 (citing Wilson, 370 Md. at 203). We held that the expert, offering a novel
medical conclusion based on underlying generally accepted medical principles, was
therefore subject to a Frye-Reed hearing.
To reach that conclusion, we distinguished CSX Transportation, Inc. v. Miller, 159
Md. App. 123 (2004) and Myers v. Celotex Corp., 88 Md. App. 442 (1991). In those cases,
the Court of Special Appeals held that a Frye-Reed hearing was unnecessary to admit a
medical expert opinion regarding the origin of a patient’s illness. See CSX, 159 Md. App.
at 187 (etiology of arthritis); Myers, 88 Md. App. at 458–59 (asbestos causing cancer). The
difference between those cases and Chesson I, we noted, was that CSX and Myers involved
generally accepted medical conclusions based on generally accepted medical principles.
Chesson I, 399 Md. at 331–32.
The “drift” continued in Blackwell, 408 Md. at 575, when we adopted the “analytical
gap” concept discussed by the Supreme Court in Joiner, 522 U.S. at 146. There, we
conducted a Frye-Reed analysis of the supposed causal relationship between childhood
vaccines and autism. The “essence” of the issue before us was whether the Frye-Reed test
applied “to the analysis undertaken by an expert where the underlying data and methods
for gathering this data are generally accepted in the scientific community but applied to
15
support a novel theory” of medical causation. Blackwell, 408 Md. at 596. We drew from
federal Daubert decisions because we never “had occasion to scrutinize the analytical
phase of a scientific process underlying a novel scientific opinion, where the underlying
data may otherwise be generally accepted in the scientific community.” Id. at 604–05.
Because generally accepted methodology “must be coupled with generally accepted
analysis in order to avoid the pitfalls of an ‘analytical gap,’” we concluded that the medical
expert opinion was not generally accepted in the scientific community notwithstanding a
basis in generally accepted methods. Id. at 608–09.
We reaffirmed the “analytical gap” concept in Chesson II, noting that although
“[g]eneral acceptance does not equate to unanimity of opinion within a scientific
community . . . [a] trial judge [] cannot admit expert testimony based on scientific
methodology without consideration of whether the analysis itself is flawed and posits an
‘analytical gap.’” 434 Md. at 356–57 (quoting Blackwell, 408 Md. at 608). On appeal
from the remand in Chesson I, we held that the “differential diagnosis”9 process—a
9
See Chesson I, 434 Md. at 350 n.2 (“Differential diagnosis, a process critiqued in
Blackwell[] to prove that thimersol caused autism, was characterized in that case as ‘a
process of elimination, [and] defined as, “[t]he process of weighing the probability of one
disease versus that of other diseases possibly accounting for a patient’s illness. The
differential diagnosis of rhinitis (a runny nose) includes allergic rhinitis (hayfever), the
abuse of nasal decongestants and, of course, the common cold.”’”).
16
generally accepted diagnostic method—the expert used to reach his causation conclusion,
was a distortion of that methodology.
The “analytical gap” concept was on display recently in Savage, 455 Md. at 138. In
that murder case, the defendant sought to bolster his theory of self-defense by expert
testimony. The expert would have testified that prior traumatic brain injuries could have
caused the defendant to perceive non-threatening actions as threatening. After a Frye-Reed
hearing, the circuit court excluded the testimony. On appeal, we affirmed, holding that the
expert’s “analysis did not bridge the ‘analytical gap’ between the data available to him and
his ultimate conclusions.” Id. at 158.
We concluded that the expert’s
ultimate opinions, that “under such conditions of chaos and stress” [the
defendant] “would be more likely to perceive himself to be facing an
imminent threat and have greater difficulty controlling his reactions[,]” and
that “[defendant] views the world through an untrusting and suspicious
perspective, and often is hyper-vigilant to possible threats[,]” are conclusory.
***
[W]e are unable to conclude that [the expert] adequately “connected the dots”
between the empirical foundation from his study of [defendant] and the
[expert’s] ultimate opinions. We emphasize that, in passing on whether there
exists an “analytical gap” between the data and the expert’s conclusions, we
may take as given the general acceptance of the expert’s methods.
Id. at 164, 170.
Judge Sally D. Adkins, concurring in Savage, argued that the Court should adopt
the Daubert standard because the “check for an ‘analytical gap’ has muddied our approach
to expert testimony.” Id. at 186 (Adkins, J., concurring). In her view, Maryland Rule 5-
17
702 “serves as a sufficient bulwark for preventing shoddy scientific testimony.” We
discuss Rule 5-702 in greater detail below.
3. The Second “Drift”: New and Old Methods.
In Reed, we adopted the Frye standard, stating that “if a new scientific technique’s
validity is in controversy in the relevant scientific community, or if it is generally regarded
as an experimental technique, then expert testimony based upon its validity cannot be
admitted into evidence.” 283 Md. at 381 (emphasis added). In practice, however,
Maryland courts have liberalized the standard, applying Frye-Reed “to testimony based on
any scientific principle—new or old.” Savage, 455 Md. at 180 (Adkins, J., concurring).
For example, in Clemons v. State, we defined a Frye-Reed standard that “makes
evidence emanating from a novel scientific process inadmissible absent a finding that the
process is generally accepted by the relevant scientific community.” 392 Md. 339, 344,
365 (2006) (emphasis added). Despite purportedly limiting the standard to “novel
scientific process[es],” we applied Frye-Reed to comparative bullet lead analysis10—a
forty-year-old and widely used scientific process. We concluded that the timeworn process
did not satisfy Frye-Reed “because several fundamental assumptions underlying the
process are not generally accepted by the scientific community.” Id. at 372. Similarly, in
State v. Baby, we held that expert testimony regarding rape trauma syndrome was subject
to Frye-Reed despite acknowledging that the syndrome was first recognized in 1974. 404
10
Comparative bullet lead analysis is “a three-step process that involves the comparison of
the elemental composition of bullets in an effort to determine whether different bullets
originated from the same vat of lead.” Clemons v. State, 392 Md. 339, 347 (2006).
18
Md. 220, 271 (2008). “Thus, like Daubert, we have implicitly recognized that a trial
judge’s gatekeeping function should not be limited to new scientific theories—old ‘junk
science’ should be kept out of our courts as well.” Savage, 455 Md. at 180 (Adkins, J.,
concurring).
Still, “[d]espite our repeated assertions that Frye-Reed applies only to new scientific
methods, we have never defined what constitutes a new or novel scientific method. We
have never held that a scientific method is not subject to Frye-Reed because it is not new.”
Id. at 181 n.5 (citations omitted) (citing Chesson I, 399 Md. at 327 (explaining that Frye-
Reed requires a party to “establish first that any novel scientific method is reliable and
accepted generally in the scientific community before the court will admit expert testimony
based upon [it]” (citation omitted)); Clemons, 392 Md. at 363 (explaining that Reed
adopted a standard for the admission of “novel scientific techniques”); Wilson, 370 Md. at
201 (“[P]rior to the admission of expert testimony based on the application of new
scientific techniques, it must be first established that the particular scientific method is
itself reliable.” (citation omitted))).
It is also well established that trial courts may take judicial notice when a scientific
method is broadly and generally accepted. Chesson I, 399 Md. at 327; Wilson, 370 Md. at
201 (“Where the validity and reliability of a scientific technique is so broadly and generally
accepted within the scientific community, as is the case of ballistic tests, blood tests, and
the like, a trial court may take judicial notice of its reliability.” (citation omitted)). Given
that “general acceptance” is the hallmark of Frye-Reed, our suggestion that trial courts take
judicial notice of generally accepted methods implies that all scientific testimony is, in
19
some sense, subject to Frye-Reed. In Dixon v. Ford Motor Co., for example, we stated that
a Frye-Reed analysis is required “only when the proposed expert testimony involves a
‘novel scientific method,’” yet we took judicial notice of the scientific method’s general
acceptance:
We may take judicial notice from our own decisions that the scientific
community accepts the proposition that exposure to asbestos may cause
mesothelioma. That is not a novel scientific principle. More than 20 years
ago . . . we flatly rejected the assertion that mesothelioma cannot be caused
by exposure to chrysotile asbestos. Thus, [the expert’s] opinion that
exposure to chrysotile asbestos in Ford brakes may cause mesothelioma also
is not a novel scientific principle.
433 Md. 137, 149–50 (2013) (footnote omitted).
We acknowledge, as we have done on several occasions, that the modern Frye-Reed
standard is not what it was when we adopted the test in 1978.
4. Maryland Rule 5-702.
Upon recommendation of the Rules Committee, this Court adopted Rule 5-702 in
1994, a year after the Supreme Court issued the opinion in Daubert:
Expert testimony may be admitted, in the form of an opinion or otherwise, if
the court determines that the testimony will assist the trier of fact to
understand the evidence or to determine a fact in issue. In making that
determination, the court shall determine (1) whether the witness is qualified
as an expert by knowledge, skill, experience, training, or education, (2) the
appropriateness of the expert testimony on the particular subject, and (3)
whether a sufficient factual basis exists to support the expert testimony.
In adopting our counterpart to FRE 702, we blessed a Committee Note that stated that Rule
5-702 was not intended to overrule Reed or other cases adopting the Frye standard, and
that “[t]he required scientific foundation for the admission of novel scientific techniques
20
or principles is left to development through case law.” Comm. Note to Md. Rule 5-702;
see Burral v. State, 352 Md. 707, 738 (1999).
In Stevenson I, we closely examined the third prong of Rule 5-70211—sufficient
factual basis. 454 Md. at 286. Judge Adkins, writing for the Court, noted that “sufficient
factual basis” includes two sub-elements: (1) an adequate supply of data; and (2) a reliable
methodology. Id. (citing Roy v. Dackman, 445 Md. 23, 42–43 (2015); Exxon Mobil Corp.
v. Ford, 433 Md. 426, 478 (2013)). Absent either element, the opinion is “mere speculation
or conjecture.” Id. (quoting Exxon, 433 Md. at 478). Because we held that Dr. Hall-
Carrington’s causation opinion lacked an adequate supply of data, we did not reach the
reliable methodology element. We also declined to address the second question on
certiorari—whether the circuit court should have held a Frye-Reed hearing—because our
Rule 5-702 conclusion was dispositive. See Sissoko, 236 Md. App. at 713 (discussing
Stevenson I and noting that “expert opinion testimony that does not satisfy the criteria for
admissibility under Rule 5-702 is not admissible even if it satisfies the Frye-Reed general
acceptance test”).
One month later, Judge Adkins issued her concurrence in Savage. On Rule 5-702,
Judge Adkins pointed to Blackwell to describe the duplicity of applying Frye-Reed to Rule
5-702:
In Blackwell’s Frye-Reed discussion, we acknowledged that
“reliability . . . affect[s] whether a scientific theory is accepted in the field in
which it is offered.” 408 Md. at 584, 971 A.2d 235. We turned to federal
11
Like the present case, the first two prongs of the Rule 5-702 analysis—witness
qualification and appropriateness—were not at issue in that appeal.
21
case law to define the contours of this term because of Daubert’s emphasis
on reliable expert testimony. Id. at 604–07, 971 A.2d 235, 260. We
concluded that the expert’s testimony was inadmissible under Frye-Reed, in
part, because his research was not “based upon sound methodology.” Id. at
609, 971 A.2d 235, 260. Thus, our evaluation of whether a conclusion was
generally accepted included inquiry as to whether the methodology used was
reliable—one of the 5-702(3) subfactors. See Roy, 445 Md. at 42–43, 124
A.3d 169. Accordingly, to determine the admissibility of expert testimony
under our direction in Blackwell, a trial court may have to analyze the
reliability of an expert’s methodology twice—once under Frye-Reed and
again under Rule 5-702(3). Adopting the Daubert approach and confining
our evaluation of scientific expert testimony to the requirements of Rule 5-
702 would eliminate this repetition.
Savage, 455 Md. at 184 (Adkins, J., concurring) (omissions and alterations in original).
Thus, according to the concurrence, “[t]he evolution of our Frye-Reed doctrine to both
maintain the general acceptance test and include a check for an “analytical gap” has
muddied our approach to expert testimony.” Id. at 186. Judge Adkins suggested that the
Court use its discretion under Rule 8-131(a)12 to adopt Daubert. In doing so, she
distinguished Savage from the majority opinion in Stevenson I:
Acknowledging our implicit adoption of Daubert would not only be
“desirable to guide the trial court” in this case but would also provide clarity
to Maryland courts. See Md. Rule 8-131(a). Furthermore, unlike [Stevenson
I], our most recent case addressing the admissibility of scientific expert
testimony, we can only dispose of the case at hand by applying Frye-Reed.
In [Stevenson I], we declined to address the parties’ arguments regarding
Frye-Reed and instead held that the expert testimony was inadmissible under
Rule 5-702 because the petitioner had appealed the trial court’s
determination as to both standards. Here, Savage only challenges the
exclusion of [the expert’s] testimony under Frye-Reed.
12
“Ordinarily, the appellate court will not decide any other issue unless it plainly appears
by the record to have been raised in or decided by the trial court, but the Court may decide
such an issue if necessary or desirable to guide the trial court or to avoid the expense and
delay of another appeal.” Md. Rule 8-131(a).
22
Savage, 455 Md. at 175 n.1 (Adkins, J., concurring) (citation omitted).
Most recently, in Sugarman v. Liles, another opinion authored by Judge Adkins, we
revisited the same EPA-ISA papers at issue in Stevenson I and the present case. 460 Md.
396 (2018). Unlike Stevenson I, we held that the EPA-ISA supplied a sufficient factual
basis under Rule 5-702(3) for a pediatrician’s general causation opinion that elevated blood
lead levels can cause deficits in auditory encoding and processing speed. In so holding,
we discussed extrajurisdictional cases that address the “analytical gap” concept, including
King v. Burlington North Santa Fe Railroad Co., 762 N.W.2d 24 (Neb. 2009). In that case,
the Supreme Court of Nebraska reversed a trial court order excluding an expert’s opinion
that exposure to diesel exhaust fumes had caused the plaintiff’s late husband to develop a
blood cancer, because the expert relied upon epidemiological studies that did not “draw
definitive conclusions on causation.” King, 762 N.W.2d at 48.
In Sugarman, we cited King with approval, explaining that an expert may rely on
scientific studies that do not make “definite conclusions of a causal relationship,” so long
as they are “qualified to interpret and extrapolate from the relevant studies.” Sugarman,
460 Md. at 427. Thus, the pediatrician expert witness was permitted to extrapolate from
the EPA-ISA that exposure to lead can cause attention decrements to opine that it also
could cause slower processing speed and auditory encoding deficits, which were “factors
of attention.” Id. at 428.
Once again, we distinguished that case from Stevenson I:
There, the expert lacked “epidemiological studies—or other reliable
evidence—demonstrating a causal link between lead exposure and ADHD”
but nonetheless offered a causation opinion. A causal relationship between
23
lead exposure and some symptoms of ADHD did not warrant testimony
linking the two. The symptoms, we observed, were present in a “variety of
other disorders and learning disabilities.” ADHD, however, has precise
diagnostic criteria and requires ruling out other behavioral disorders.
Further, the EPA-ISA emphasized other potential confounding factors that
undermined Dr. Hall-Carrington’s opinion. The EPA-ISA could not support
her opinion because the studies discussed therein “only reveal an association
between lead exposure and ADHD.” Her opinion lacked an adequate factual
basis because the source did not logically support her conclusion.
Here, by contrast, the EPA-ISA identified a causal relationship
between attention decrements and exposure to lead. Unlike in [Stevenson I],
none of the experts opined that Liles has a diagnosable learning disability or
behavioral disorder. [The pediatrician] explained lead’s impact on a
developing brain, including the way it affects attention. She offered the
opinion that Liles suffered from the kind of generalized attention deficits the
EPA-ISA identified as being caused by lead exposure. Because [the
pediatrician’s] opinion testimony does not suffer the same defects as were
present in [Stevenson I], we hold that she had a sufficient factual basis to
offer an opinion regarding general causation.
Id. at 428–29 (emphasis and citations omitted). The dissent in Sugarman disagreed, instead
suggesting that “this case suffers a somewhat distinct, but nonetheless significant,
analytical gap as was present in” Stevenson I. Id. at 450 (Getty, J., concurring in part and
dissenting in part).
We have therefore held, under our Frye-Reed jurisprudence, that the EPA-ISA
epidemiological studies can provide a sufficient factual basis to offer an expert opinion as
to general causation of attention decrements. Regardless of whether we apply Daubert or
the modern Frye-Reed standard, the question then becomes: is this specific causation case
a Stevenson I case, where the analytical gap was too vast, or a Sugarman case where the
analytical gap was sufficiently bridged? We do not answer that question, but remand the
case for a hearing on the subject applying the Daubert standard we adopt today.
24
C. We Adopt Daubert.
Maryland’s “jurisprudential drift” has led to a duplicative analytical process and
“muddied” the waters of our approach to expert testimony. Savage, 455 Md. at 186, 187(Adkins, J., concurring). Instead of perpetuating a process wherein expert testimony must
pass through Frye-Reed and Rule 5-702, we implement a single standard by which courts
evaluate all expert testimony: Daubert. Courts, practitioners, and scholars alike have
grappled with the advantages and disadvantages of the Daubert standard over the decades
since the Supreme Court first articulated the factored test. Because our decision today is a
substantial departure from our Frye-Reed jurisprudence, we explain the reasons that guide
us.
1. The Circuit Court Abused Its Discretion.
The circuit court did not contemplate any of the above legal considerations. Instead,
the court relied solely on the opinion in Stevenson I. The determination in Stevenson I that
Dr. Hall-Carrington could not testify that lead generally or specifically caused ADHD—
and the analysis thereto—led the circuit court to properly conclude that Dr. Hall-Carrington
could testify that lead can cause attention decrements, hyperactivity, and impulsivity in the
general population. But it does not follow, merely based on the Stevenson I opinion, that
the EPA-ISA supports a finding that lead specifically caused Ms. Stevenson’s attention
decrements, hyperactivity, and impulsivity.
As a practical matter, the circuit court erred by refusing to hold a Rule 5-702 hearing
at which Dr. Hall-Carrington could explain, and Mr. Rochkind could cross-examine, the
specific causation methodology that is the subject of this appeal. Rather than conduct an
25
evidentiary hearing to analyze the methodology employed by Dr. Hall-Carrington, the
circuit court stated that based on its reading of the opinion in Stevenson I that Dr. Hall-
Carrington could render the same opinions, as in Stevenson I, so long as she did not use the
term “ADHD.” Mr. Rochkind objected, noting that (1) the Court never reached the specific
causation issue in Stevenson I; and (2) Dr. Hall-Carrington had no methodology to render
such an opinion. Mr. Rochkind thereafter filed additional briefing and an extensive written
offer of proof in support of his objection. When the court denied the motion for a pretrial
hearing, Mr. Rochkind was compelled to challenge Dr. Hall-Carrington’s methodology in
front of the jury. This placed Mr. Rochkind in exactly the situation a pretrial hearing is
designed to prevent. See Blackwell, 408 Md. at 591, 594 n. 13 (describing pre-trial
evidentiary hearing contemplated under Maryland law to challenge expert testimony and
reasons therefor); Savage, 455 Md. at 170 (noting that experts should not be connecting
the dots in front of jury).
The circuit court abused its discretion by not holding a Rule 5-702 hearing. Given
that we are remanding the case so that the circuit court can conduct a hearing pursuant to
Maryland Rule 5-702, as part of the remand, the circuit court should consider
the Daubert standard adopted herein.
26
2. The “Right” Case.
Ms. Stevenson maintains that the instant case is not the “appropriate catalyst” for
this Court to abandon the Frye-Reed standard in favor of the Daubert standard. We
disagree.13
The standard by which expert testimony is evaluated is judicially determined by this
Court. Within our purview, as charged by the Maryland Constitution, is our duty to “adopt
rules and regulations concerning the practice and procedure” in Maryland courts. 14 With
this duty, we have adopted Maryland Rule 5-702. When this Court effects a change to the
common law, as it does today, the Maryland Rules undergo revision to reflect such change.
We are not bound to the Rules when the need to alter common law arises. Indeed, the 1994
13
Notwithstanding the fact that this Court granted certiorari to answer the very question of
whether to adopt Daubert, the Dissent also argues that “[t]his case is plainly not the case
in which to entertain” adopting Daubert. Dissenting Slip Op. at 14. The Dissent relies on
an interaction between the circuit court and Mr. Rochkind’s counsel to conclude that
“Rochkind’s counsel explicitly agreed with the circuit court that a Frye-Reed hearing was
not appropriate under the[se] circumstances.” Id. After a full reading of the record,
however, we are satisfied that up until that point, Mr. Rochkind sufficiently pursued a Frye-
Reed hearing. Mr. Rochkind presented his Frye-Reed arguments several times over. Prior
to the interaction quoted by the Dissent, Mr. Rochkind’s counsel filed a motion and argued
several times at the motions hearing that a Frye-Reed hearing was needed. Only at a later
hearing did counsel for Mr. Rochkind concede that a Rule 5-702 hearing would be
sufficient. We therefore find unavailing the Dissent’s argument that the principles of Frye-
Reed were not before the circuit court because “it was clear that [the] case was decided
under Maryland Rule 5-702, not under Frye-Reed.” Id. at 15. A “Frye-Reed hearing was
not appropriate” only because the circuit said so, not for lack of preservation. See id. at
14; see also Md. Rule 8-131(a).
14
Md. Const., Art. IV, Section 18(a) (“The Court of Appeals from time to time shall adopt
rules and regulations concerning the practice and procedure in and the administration of
the appellate courts and in the other courts of this State, which shall have the force of law
until rescinded, changed or modified by the Court of Appeals or otherwise by law.”).
27
Committee Note accompanying Rule 5-702 confirms as much: “[t]he required scientific
foundation for the admission of novel scientific techniques or principles is left to
development through case law.” The time has now come to plot a new course, overruling
our Frye-Reed jurisprudence and finding Daubert factors persuasive, with regard to the
analysis of expert testimony.
Surely, our decision today implicates the doctrine of stare decisis. “Latin for ‘to
stand by things [that are] decided,’” stare decisis ordinarily requires that a court “follow
earlier judicial decisions when the same points arise again in litigation.” Kazadi v. State,
467 Md. 1, 27 (2020) (quoting Black’s Law Dictionary (11th ed. 2019)). However, the
doctrine “is not an inexorable command.” Savage, 455 Md. at 186 (Adkins, J., concurring)
(quoting Conover v. Conover, 450 Md. 51, 65 (2016)). This Court has articulated two
circumstances where a departure from the doctrine of stare decisis is permissible: “(1)
when the prior decision is clearly wrong and contrary to established principles[;] or (2)
when the precedent has been superseded by significant changes in the law or facts.” Id.(internal quotation marks omitted) (quoting Conover, 450 Md. at 65). Over the last forty
years, Maryland’s appellate courts have considerably modified the Frye-Reed standard.
The Frye-Reed of 1978 is markedly different than the “Frye-Reed Plus” of 2020. With
Daubert, and eventually Joiner and Kumho Tire, the Supreme Court disavowed the Frye
standard for the more flexible Daubert approach. A supermajority of our sister
28
jurisdictions followed suit. Clearly, a significant change in the law has occurred,
permitting us to depart from stare decisis and adopt the Daubert standard in this instance.15
15
The Dissent and Ms. Stevenson argue that if Maryland is to adopt Daubert, the Rules
Committee, rather than this Court, should be the body to do so. Yet, we resist the call to
refer this matter to the Rules Committee for several reasons. As discussed above and noted
by the 1994 Committee Note to Rule 5-702, “[t]he required scientific foundation for the
admission of novel scientific techniques or principles is left to development through case
law.” Of course, at that time, the Rules Committee was referring to the Frye-
Reed standard. Yet, in the same Committee Note, the Rules Committee explicitly
acknowledged Daubert, and made sure to indicate that Rule 5-702 is not intended to
overrule Frye-Reed. We glean from the Note that the Rules Committee
considered Daubert in 1994, but left it to this Court to change the standard applied to
scientific testimony.
Adopting Daubert is in line with our longstanding view that Maryland’s courts look to
federal cases when interpreting analogous federal rules. See Bartell v. Bartell, 278 Md. 12,
18 (1976). Rule 5-702 was adopted in 1994 to track FRE 702. See Hutton v. State, 339
Md. 480, 494 n.10 (1995); see also Wood v. Toyota Motor Corp., 134 Md. App. 512, 523
n.13 (2000) (observing that Maryland’s “case law is consistent with the [2000]
amendments to Rule 702 of the Federal Rules of Evidence,” which expressly
adopted Daubert).
In part, the Dissent suggests that the Rules Committee is the more appropriate forum to
study the potential impact the Daubert standard will have on “African American people,
people of color, or people of limited financial means.” Dissenting Slip Op. at
18; see Andrew W. Jurs and Scott DeVito, A Tale of Two Dauberts: Discriminatory Effects
of Scientific Reliability Screening, 79 Ohio St. L.J. 1107, 1144 (2018). We do not reject
the seriousness of this contention. We do, however, note other scholarly research coming
to the opposite conclusion. See Edward K. Cheng & Albert H. Yoon, Does Frye or
Daubert Matter? A Study of Scientific Admissibility Standards, 91 Va. L. Rev. 471, 503
(2005) (“[A] state’s choice of scientific admissibility standard does not have a statistically
significant effect . . . [and] a state’s adoption of Frye or Daubert makes no difference in
practice.”). This Court is well suited to weigh the advantages and disadvantages of
modifying our approach to any area of the law—as we often do. That this change
implicates our interpretation of the Maryland Rules does not necessitate a referral to the
Rules Committee.
29
3. Daubert: Generally Accepted by the Supermajority of Jurisdictions.
Judge Adkins’ concurring opinion in Savage blazed the trail for this Court’s
adoption of the Daubert standard. Considering the breadth of scholarly arguments
supporting and discounting the Daubert standard, and Maryland’s prolonged—albeit
nominal at times—adherence to the Frye-Reed standard, we now explain our decision to
join the supermajority of sister states and the federal courts on this issue.
We recognize that this Court’s jurisprudence has implicitly embraced portions of
the Daubert standard in the Frye-Reed analysis without expressly stating that fact. See
supra at 14–20. Recognizing our “drift,” we agree with Mr. Rochkind that retaining a
Frye-Reed standard, yet encouraging trial courts to seek guidance from federal cases
applying the Daubert standard, may generate some confusion.
The impetus behind our decision to adopt Daubert is our desire to refine the
analytical focus when a court is faced with admitting or excluding expert testimony. This
becomes especially important in modern society, which routinely confronts emerging
technologies that challenge the efficacy of Frye. Frye centered on whether scientific
principles or discoveries were generally accepted in a relevant scientific community. Yet,
using acceptance as the only measure of reliability presents a conundrum: a generally
accepted methodology may produce “bad science” and be admitted, while a methodology
not yet accepted may be excluded, even if it produces “good science.” See Motorola Inc.
v. Murray, 147 A.3d 751, 756 (D.C. 2016). General acceptance remains an important
consideration in the reliability analysis, but it cannot remain the sole consideration. See
Libas, Ltd. v. United States, 193 F.3d 1361, 1368 (Fed. Cir. 1999) (“While ‘[w]idespread
30
acceptance can be an important factor’ in an assessment of reliability . . . after Daubert and
Kumho [Tire], the inquiry does not necessarily end there. The lesson of the Supreme
Court’s rejection of ‘general acceptance’ as the sole standard for expert testimony, in favor
of the Daubert-Kumho reliability standard is that ‘widespread use’ or ‘general acceptance’
is an imperfect proxy for reliability.” (internal citation omitted)).
Daubert, by contrast, refocuses the attention away from acceptance of a given
methodology—although that is not totally removed from the calculus—and centers on the
reliability of the methodology used to reach a particular result. “The ability to focus on the
reliability of principles and methods, and their application, is a decided advantage that will
lead to better decision-making by juries and trial judges alike.” Motorola, 147 A.3d at 757.
In this regard, the analysis by the Honorable Paul W. Grimm in United States v.
Horn is enlightening. There, Judge Grimm explained:
Under Daubert, the parties and the trial court are forced to reckon with the
factors that really do determine whether the evidence is reliable, relevant
and “fits” the case at issue. Focusing on the tests used to develop the
evidence, the error rates involved, what the learned publications in the field
have said when evaluating it critically, and then, finally, whether it has come
be generally accepted, is a difficult task. But, if undertaken as intended, it
does expose evidentiary weaknesses that otherwise would be overlooked if,
following the dictates of Frye, all that is needed to admit the evidence is the
testimony of one or more experts in the field that the evidence at issue derives
from methods or procedures that have become generally accepted.
185 F. Supp. 2d 530, 553 (D. Md. 2002) (emphasis added). “The principle shortcoming of
Frye,” Judge Grimm continued, “was that it excused the court from even having to try to
understand the evidence at issue.” Id. (citation omitted). Instead, a Frye court “only had
to assure itself that among the people involved in the field, the technique was acceptable
31
as reliable.” Id. (quoting 4 Jack B. Weinstein & Margaret A. Berger, Weinstein’s Federal
Evidence, § 702.05[1] (2d ed. 1997)). This rationale leads to a troubling result:
given the impact of the stare decisis doctrine, once a court, relying on Frye,
had ruled that a doctrine or principle had attained general acceptance, it was
all to[o] easy for subsequent courts simply to follow suit. Before long, a
body of case law could develop stating that a methodology had achieved
general acceptance without there ever having been a contested, detailed
examination of the underpinnings of that methodology.
Id.; see supra at 19 (discussing this phenomenon in Maryland).
Other courts applying a variant of Frye have observed different flaws. The D.C.
Court of Appeals noted that Frye “is not a good gatekeeper for inductive sciences such as
epidemiology or psychology.” Motorola, 147 A.3d at 756. The Supreme Court of Alaska,
in adopting the Daubert standard, concluded that the Frye standard “is both unduly
restrictive and unduly permissive.” State v. Coon, 974 P.2d 386, 394 (Alaska 1999). The
Frye standard “excludes scientifically reliable evidence which is not yet generally
accepted, and admits scientifically unreliable evidence which although generally accepted,
cannot meet rigorous scientific scrutiny.” Id. at 393–94. For this reason, we tend to agree
with the Supreme Court of Connecticut: “an admissibility test for scientific evidence
premised solely on its ‘general acceptance’ is conceptually flawed and therefore must be
rejected.” State v. Porter, 698 A.2d 739, 750 (Conn. 1997) (emphasis in original).
Our Frye-Reed jurisprudence gave trial courts a stated “end”—reliable
methodology—without providing the “means” to achieve it. In Exxon, we observed that
“[t]o constitute reliable methodology, ‘an expert opinion must provide a sound reasoning
process for inducing its conclusion from the factual data’ and must have ‘an adequate
32
theory or rational explanation of how the factual data led to the expert’s conclusion.’” 433
Md. at 481 (citation omitted). The Daubert factors provide guidance on how to determine
if scientific reasoning is, indeed, sound, or a scientific theory adequately justifies an
expert’s conclusion.
Daubert is not beyond reproach. Ms. Stevenson levels several criticisms against
Daubert, none of which we find sufficiently persuasive to perpetuate our Frye-Reed
jurisprudence. Still, we address Ms. Stevenson’s arguments against adopting Daubert and
use the opportunity to provide Maryland trial courts with additional guidance on how to
implement this new-to-Maryland standard.
Ms. Stevenson contends that the Daubert standard enables judges to become
“arbiters of scientific knowledge” and “usurp[] the role of juries.” She argues that the
standard “sanction[s] judges to exclude from consideration opposing, yet legitimate
opinions of experts, that . . . are for a jury to weigh credibility.” We do not foresee the
same gloomy outlook. Under Daubert, judges are charged with gauging only the threshold
reliability—not the ultimate validity—of a particular methodology or theory. Ms.
Stevenson appears to believe that the inclusion of expert’s testimony will lead to the
exclusion of another; however, this simply is not true. As we shall demonstrate, it is often
helpful to turn to FRE 702 and the associated Advisory Committee Note to understand
Daubert’s application. “When a trial court, applying [FRE 702], rules that an expert’s
testimony is reliable, this does not necessarily mean that contradictory expert testimony is
unreliable. [FRE 702] is broad enough to permit testimony that is the product of competing
principles or methods in the same field of expertise.” Fed. R. Evid. 702 Advisory
33
Committee Note (emphasis added and citation omitted). Indeed, under this approach to
expert testimony, juries will continue to weigh competing, but still reliable, testimony.
Ms. Stevenson relies in part on Chief Justice Rehnquist’s concurring and dissenting
opinion in Daubert to argue that adopting this standard requires judges to take on the role
of amateur scientists. Like other courts that have considered this argument, however, we
reject it in kind. “Under Daubert, trial judges are not required to make a determination of
the ultimate scientific validity of any scientific propositions. Instead, they need only make
a much more limited inquiry: whether sufficient indicia of legitimacy exist to support the
conclusion that evidence derived from the principle may be profitably considered by a fact
finder at trial.” Porter, 698 A.2d at 757; see also E.I. du Pont de Nemours & Co. v.
Robinson, 923 S.W.2d 549, 557 (Tex. 1995) (emphasis added) (“[A] judge does not have
to be trained in science to evaluate the reliability of a theory or technique.”). We are
confident that trial judges are duly capable of undertaking the reliability analysis absent
scientific training.
Ms. Stevenson further argues that Daubert’s abuse of discretion standard and
inherent flexibility of the Daubert factors will lead to inconsistent results. We recognize,
like the D.C. Court of Appeals, that with Daubert’s flexibility, “[s]ome inconsistency is
inevitable.” Motorola, 147 A.3d at 756. The Supreme Court of Connecticut described
“Daubert’s indefiniteness not as a flaw, but as a necessity” in concluding that “a test
embodying a general, overarching approach to the threshold admissibility of scientific
evidence . . . giv[es] trial courts a workable principle to follow.” Porter, 698 A.2d at 751–
52. We remain persuaded that a marginal amount of inconsistency is preferable given that
34
this standard will “more accurately distinguish ‘good science’ from ‘bad science’ than
Frye’s general acceptance test.” Savage, 455 Md. at 185 (Adkins, J., concurring) (quoting
Motorola, 147 A.3d at 756).
As delayed as Maryland is in joining the supermajority of states and federal courts
to adopt the Daubert standard, we do so now with the added benefit of hindsight. As one
court remarked, Daubert’s application in the federal courts did not “work a sea change over
federal evidence law.” United States v. 14.38 Acres of Land, More or Less Situated in
Leflore Cty., State of Miss., 80 F.3d 1074, 1078 (5th Cir. 1996). Nor are we convinced that
adopting this standard in Maryland will upend Maryland evidence law. Instead, Maryland
courts will be able to “draw from and contribute to the broad base of case law grappling
with scientific testimony.” Savage, 455 Md. at 185 (Adkins, J., concurring). This will give
our courts a decided advantage when faced with emerging technologies we cannot yet
foresee.
Our adoption of Daubert will streamline the evaluation of scientific expert
testimony under Rule 5-702. As Judge Adkins indicated in Savage, our discussion in
Blackwell required trial courts “to analyze the reliability of an expert’s methodology
twice—once under Frye-Reed and again under Rule 5-702(3).” Savage, 455 Md. at 184(Adkins, J., concurring). Adopting Daubert eliminates the duplicative analysis and permits
trial courts to evaluate all expert testimony—scientific or otherwise—under Rule 5-702.
4. Applying Daubert.
To complete our “jurisprudential drift”—once and for all—we set forth the Daubert
factors we find persuasive in interpreting Rule 5-702. They include, but are not limited to:
35
(1) whether a theory or technique can be (and has been) tested;
(2) whether a theory or technique has been subjected to peer review and
publication;
(3) whether a particular scientific technique has a known or potential rate of
error;
(4) the existence and maintenance of standards and controls; and
(5) whether a theory or technique is generally accepted.
Daubert, 509 U.S. at 593–94 (cleaned up); Fed. R. Evid. 702 Advisory Committee Note.
In addition to these factors, courts have developed additional factors for determining
whether expert testimony is sufficiently reliable. These factors include:
(6) whether experts are proposing to testify about matters growing naturally
and directly out of research they have conducted independent of the
litigation, or whether they have developed their opinions expressly for
purposes of testifying;
(7) whether the expert has unjustifiably extrapolated from an accepted
premise to an unfounded conclusion;
(8) whether the expert has adequately accounted for obvious alternative
explanations;
(9) whether the expert is being as careful as he [or she] would be in his [or
her] regular professional work outside his [or her] paid litigation consulting;
and
(10) whether the field of expertise claimed by the expert is known to reach
reliable results for the type of opinion the expert would give.
Fed. R. Evid. 702 Advisory Committee Note (cleaned up).
The Supreme Court’s guidance in Daubert, Joiner, and Kumho Tire is critical to a
trial court’s reliability analysis. Daubert made abundantly clear that the inquiry is “a
flexible one.” Daubert, 509 U.S. at 594. “The focus, of course, must be solely on
36
principles and methodology, not on the conclusions that they generate.” Id. at 595. Yet,
Joiner clarified that “conclusions and methodology are not entirely distinct from one
another.” 522 U.S. at 146. A trial court must also consider the relationship between the
methodology applied and conclusion reached. Indeed, “[t]rained experts commonly
extrapolate from existing data. But nothing in either Daubert or the Federal Rules of
Evidence requires a [trial] court to admit opinion evidence that is connected to existing
data only by the ipse dixit of the expert.” Id. “A court may conclude that there is simply
too great an analytical gap between the data and the opinion proffered.” Id.
Kumho Tire, as noted above, extended Daubert’s application to all expert testimony.
526 U.S. at 141 (“Daubert’s general holding . . . applies not only to testimony based on
‘scientific’ knowledge, but also to testimony based on ‘technical’ and ‘other specialized’
knowledge.”). Kumho Tire also made clear that
a trial court may consider one or more of the more specific factors that
Daubert mentioned when doing so will help determine that testimony’s
reliability. But, as the Court stated in Daubert, the test of reliability is
“flexible,” and Daubert’s list of specific factors neither necessarily nor
exclusively applies to all experts or in every case. Rather, the law grants a
[trial] court the same broad latitude when it decides how to determine
reliability as it enjoys in respect to its ultimate reliability determination.
Id. at 141–42 (emphasis in original). Simply put, all of the Daubert factors are relevant to
determining the reliability of expert testimony, yet no single factor is dispositive in the
analysis. A trial court may apply some, all, or none of the factors depending on the
particular expert testimony at issue. Savage, 455 Md. at 184 (Adkins, J., concurring) (“[A]
a trial court is not required to consider any or all of the Daubert factors in making its
reliability determination.”).
37
Applying Daubert factors to our interpretation of Rule 5-702 and eliminating Frye-
Reed provides a simpler, more straightforward analysis of expert testimony. There is no
longer a need to distinguish new or novel techniques or determine if testimony embraces a
“scientific technique.” Just as this process provides a flexible structure for trial courts, so
too does it guide appellate courts reviewing the admission or exclusion of expert testimony.
Instead of maintaining two separate, and potentially outcome determinative, standards of
review—de novo for Frye-Reed and abuse of discretion for Rule 5-702—all expert
testimony is reviewed under the abuse of discretion standard.16 See Joiner, 522 U.S. at 143
(“[T]he question of admissibility of expert testimony is . . . reviewable under the abuse-of-
discretion standard.”).
5. Final Thoughts.
In light of our comments on applying Daubert, supra at 33–36, we offer a few
thoughts for judges who will shoulder the implementation of this new-to-Maryland
evidentiary standard. Much of the discussion above does not upend a trial court’s
gatekeeping function. “Vigorous cross-examination, presentation of contrary evidence,
and careful instruction on the burden of proof are the traditional and appropriate means of
16
Ms. Stevenson suggests that Frye-Reed’s de novo standard of review ensures consistency
because “[t]he science is either generally accepted as reliable in the relevant scientific
community or it is not.” Yet, this misses the mark. Ms. Stevenson conflates consistency
with complacency. To the extent that Frye-Reed rulings were consistent, it is due to the
ability of a later court to take judicial notice of a methodology’s general acceptance. We
reject this type of “consistency.” Instead, we task trial courts with analyzing the reliability
of testimony posed to it, without the notion that because a court has accepted it before, it
shall be accepted again.
38
attacking shaky but admissible evidence.” Daubert, 509 U.S. 596 (citation omitted). To
the extent that our decision necessitates change in Maryland courts, we fully endorse Judge
Grimm’s observations in Horn. The shift to Daubert
may mean, in a very real sense, that “everything old is new again” with
respect to some scientific and technical evidentiary matters long considered
settled.
***
[J]udges, lawyers and expert witnesses will have to learn to be comfortable
refocusing their thinking about the building blocks of what truly makes
evidence that is beyond the knowledge and experience of lay persons useful
to them in resolving disputes. The beneficiaries of this new approach will be
the jurors that have to decide increasingly complex cases. Daubert, Kumho
Tire, and now Rule 702 have given us our marching orders, and it is up to
the participants in the litigation process to get in step.
Horn, 185 F. Supp. 2d at 554–55.
CONCLUSION
In light of the significant changes in the law concerning expert testimony, as
established by Daubert and its progeny, we adopt the Daubert standard in Maryland
because we find those factors persuasive in interpreting Maryland Rule 5-702. Since
Daubert is a new interpretation of Rule 5-702, our decision today “applies to this case and
any other cases that are pending on direct appeal when this opinion is filed, where the
relevant question has been preserved for appellate review.” Kazadi, 467 Md. at 47;
Hackney v. State, 459 Md. 108, 119 (2018); State v. Daughtry, 419 Md. 35, 77 n.26 (2011).
In this context, the “relevant question” is whether a trial court erred in admitting or
excluding expert testimony under Maryland Rule 5-702 or Frye-Reed. Therefore, to apply
39
this new evidentiary standard, we remand this case to the Circuit Court for Baltimore City
for further proceedings.
JUDGMENT OF THE CIRCUIT COURT
FOR BALTIMORE CITY REVERSED.
CASE REMANDED TO THAT COURT
FOR PRETRIAL PROCEEDINGS AND A
NEW TRIAL CONSISTENT WITH THIS
OPINION. COSTS TO BE PAID BY
APPELLEE/PETITIONER.
40
Circuit Court for Baltimore City
Case No. 24-C-11-008722
Argued: February 7, 2020
IN THE COURT OF APPEALS
OF MARYLAND
No. 47
September Term, 2019
______________________________________
STANLEY ROCHKIND
v.
STARLENA STEVENSON
______________________________________
McDonald
Watts
Hotten
Getty
Booth
Biran
Greene, Clayton, Jr., (Senior
Judge, Specially Assigned),
JJ.
______________________________________
Dissenting Opinion by Watts, J., which Hotten
and Greene, JJ., join.
______________________________________
Filed: August 28, 2020
Respectfully, I dissent. I disagree with the adoption of the Daubert standard, derived
from Daubert v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). See Maj. Slip
Op. at 2, 39. I would hold that the issue of whether or not to move from the Frye-Reed
analysis and adopt the Daubert standard for the admissibility of expert testimony in
Maryland is not a matter that the Court should decide in this case, i.e., this case is not the
proper one in which to make such a change. And, I disagree with the majority opinion that
the case should be remanded to the Circuit Court for Baltimore City for application of the
Daubert standard. See Maj. Slip Op. at 39. I would hold that the circuit court did not abuse
its discretion in admitting the testimony of Cecilia Hall-Carrington, M.D., and that the
testimony satisfied the requirements of Maryland Rule 5-702, without the need to resort to
the application of Frye-Reed or Daubert. The circuit court did not evaluate the
admissibility of Dr. Hall-Carrington’s testimony under either Frye-Reed or Daubert, but
instead addressed the matter only under Maryland Rule 5-702. Adopting the Daubert
standard at this time for use in this case would change the analysis of the case on remand
when nothing about the case warrants such a change and no change in existing law is
necessary.
At the outset, it would be helpful to discuss the different standards pertaining to the
admissibility of expert testimony. In general, Maryland Rule 5-702 governs the
admissibility of expert testimony and provides:
Expert testimony may be admitted, in the form of an opinion or otherwise, if
the court determines that the testimony will assist the trier of fact to
understand the evidence or to determine a fact in issue. In making that
determination, the court shall determine (1) whether the witness is qualified
as an expert by knowledge, skill, experience, training, or education, (2) the
appropriateness of the expert testimony on the particular subject, and (3)
whether a sufficient factual basis exists to support the expert testimony.
The third prong—sufficient factual basis—has been interpreted to include two sub-factors:
an adequate supply of data and a reliable methodology with which to analyze the data. See
Roy v. Dackman, 445 Md. 23, 42-43, 124 A.3d 169, 180 (2015).
In Reed v. State, 283 Md. 374, 391 A.2d 364 (1978), this Court adopted the standard
set forth by the United States Court of Appeals for the District of Columbia Circuit in Frye
v. United States, 293 F. 1013, 1014 (D.C. Cir. 1923), setting forth a requirement for the
admissibility of expert testimony that is based on a novel scientific method. Under the
standard known as the Frye-Reed analysis, a trial court must determine as a threshold
matter whether a novel scientific method is generally accepted within the relevant scientific
community before testimony based on that method can be admitted. See Reed, 283 Md. at
381, 389, 391 A.2d at 368, 372; see also Dixon v. Ford Motor Co., 433 Md. 137, 149-50,
70 A.3d 328, 335 (2013) (“A Frye/Reed analysis is required, as a prerequisite to the
application of Rule 5-702, only when the proposed expert testimony involves a ‘novel
scientific method,’ in which event there must be some assurance that the novel method has
gained general acceptance within the relevant scientific community.”). In such
circumstances, the trial court conducts a Frye-Reed hearing, which is a “pretrial hearing at
which the proponent of the scientific evidence must establish such general acceptance if
the admissibility of the evidence is challenged.” Phillips v. State, 451 Md. 180, 184 n.1,
152 A.3d 712, 714 n.1 (2017).
By contrast, federal courts and a number of States utilize the Daubert approach,
-2-
derived from the United States Supreme Court’s decision in Daubert, 509 U.S. 579, for the
admissibility of expert testimony on scientific matters. In Daubert, id. at 588, relying on
the language of Federal Rule of Evidence 702, the Supreme Court acknowledged that Rule
702 did not “establish[] ‘general acceptance’ as an absolute prerequisite to admissibility.”
At that time, Federal Rule of Evidence 702 governing expert testimony provided: “If
scientific, technical, or other specialized knowledge will assist the trier of fact to
understand the evidence or to determine a fact in issue, a witness qualified as an expert by
knowledge, skill, experience, training, or education, may testify thereto in the form of an
opinion or otherwise.” Daubert, 509 U.S. at 588. The Supreme Court held that Rule 702’s
standards, not the general acceptance standard set forth in Frye, should be applied with
respect to the admissibility of scientific expert testimony. See Daubert, 509 U.S. at 589.
The Supreme Court explained that, before admitting expert testimony on scientific matters,
a trial court must determine as a preliminary matter, “whether the reasoning or
methodology underlying the testimony is scientifically valid and [] whether that reasoning
or methodology properly can be applied to the facts in issue.” Id. at 592-93.
The Supreme Court provided “general observations” about how a trial court should
assess the validity and reliability of scientific expert testimony, and set forth the following
factors: (1) “whether a theory or technique . . . can be (and has been) tested”; (2) “whether
the theory or technique has been subjected to peer review and publication”; (3) “the known
or potential rate of error, and the existence and maintenance of standards controlling the
technique’s operation”; and (4) “general acceptance.” Id. at 593-94 (cleaned up). As to
“general acceptance,” the Supreme Court pointed out that “[a] reliability assessment does
-3-
not require, although it does permit, explicit identification of a relevant scientific
community and an express determination of a particular degree of acceptance within that
community.” Id. at 594 (cleaned up). The Supreme Court explained that the approach it
set forth under Rule 702 is “a flexible one” and “[t]he focus . . . must be solely on the
principles and methodology, not on the conclusions that they generate.” Id. at 594-95.
The Supreme Court has since elaborated on the Daubert analysis. In General
Electric Co. v. Joiner, 522 U.S. 136, 146 (1997), the Supreme Court rejected the contention
that Daubert only permits a trial court to evaluate the methodology of studies and not an
expert’s conclusions. The Supreme Court explained: “Trained experts commonly
extrapolate from existing data. But nothing in either Daubert or the Federal Rules of
Evidence requires a [trial] court to admit opinion evidence that is connected to existing
data only by the ipse dixit of the expert.” Id. The Supreme Court recognized that a trial
court could “conclude that there is simply too great an analytical gap between the data and
the opinion proffered.” Id. In Kumho Tire Co. v. Carmichael, 526 U.S. 137, 148-49
(1999), the Supreme Court held that the “gatekeeping” standard and “general principles”
of Daubert applied to all expert testimony governed by Federal Rule of Evidence 702,
meaning “scientific,” “technical,” and “other specialized” testimony. The Supreme Court
also explained that the Daubert factors are “meant to be helpful, not definitive[,]” and
“[i]ndeed, those factors do not all necessarily apply even in every instance in which the
reliability of scientific testimony is challenged.” Id. at 151.
Over the past several years, there has been discussion in the legal community that
Maryland utilizes a standard that is a hybrid of Frye-Reed and Daubert, and speculation
-4-
that Maryland has been moving from Frye-Reed to Daubert. In 2009, in Blackwell v.
Wyeth, 408 Md. 575, 591, 605, 971 A.2d 235, 245, 253 (2009), in reviewing Frye-Reed
jurisprudence, this Court stated that various federal courts had “had occasion to scrutinize
the reliability of the analytical framework utilized by an expert in formulating a novel
theory of science” and we observed “that they utilized the Daubert standard rather than
Frye.” (Cleaned up). We noted that the concept of the “analytical gap” had developed
beginning with Joiner, 522 U.S. at 146, and that the “analytical gap” concept had been used
by federal courts applying Daubert and by some State courts applying Frye. See Blackwell,
408 Md. at 604-07, 971 A.2d at 253-54. After reviewing relevant case law, we concluded
that “[g]enerally accepted methodology[ ] must be coupled with generally accepted
analysis in order to avoid the pitfalls of an ‘analytical gap.’” Id. at 608, 971 A.2d at 255.
In other words, this Court incorporated the concept of the “analytical gap” into Maryland’s
Frye-Reed analysis.
In Rochkind v. Stevenson, 454 Md. 277, 295-96, 164 A.3d 254, 265 (2017)
(“Stevenson I”), when this case first came to the Court, we applied the “analytical gap”
concept under Maryland Rule 5-702(3) and held that the expert’s (Dr. Hall-Carrington’s)
testimony lacked a sufficient factual basis, as required by the Rule, and that the circuit court
abused its discretion in allowing Dr. Hall-Carrington to render an opinion that lead
exposure can cause ADHD generally and that lead caused Stevenson’s ADHD specifically.
In so holding, we explained that the circuit court had “failed to determine whether
Stevenson’s proffered sources logically supported Dr. Hall-Carrington’s opinion that lead
exposure can cause ADHD.” Id. at 295, 164 A.3d at 264. We applied the concept of the
-5-
“analytical gap” and concluded that the circuit court clearly erred by “fail[ing] to check for
an ‘analytical gap’ between the expert’s data and her conclusion.” Id. at 295, 164 A.3d at
264. Notably, in Stevenson I, id. at 295, 164 A.3d at 265, because we concluded that Dr.
Hall-Carrington’s ADHD causation testimony should have been excluded under Maryland
Rule 5-702, we declined to reach the issue of whether the circuit court should have held a
Frye-Reed hearing as to Dr. Hall-Carrington’s general causation testimony.
A few weeks later, this Court issued its opinion in Savage v. State, 455 Md. 138,
166 A.3d 183 (2017). In Savage, id. at 159, 166 A.3d at 195, we quoted approvingly from
Giddens v. State, 148 Md. App. 407, 415-16, 812 A.2d 1075, 1080 (2002), cert. denied,
374 Md. 83, 821 A.2d 370 (2003), in which the Court of Special Appeals explained:
Frye sets forth only a legal standard which governs the trial judge’s
determination of a threshold issue. Testimony based on a technique which
is found to have gained “general acceptance in the scientific community”
may be admitted into evidence, but only if a trial judge also determines in the
exercise of his discretion, as he must in all other instances of expert
testimony, that the proposed testimony will be helpful to the jury, that the
expert is properly qualified, etc. Obviously, however, if a technique does not
meet the Frye standard, a trial judge will have no occasion to reach these
further issues.
...
It is also well settled, however, that if the relevant scientific community is in
general agreement that a properly conducted scientific test will produce an
accurate result, the Frye-Reed test does not operate to exclude conflicting
expert opinions based upon such a test.
We explained that there was “no reason to depart from this standard in the appropriate case
where it applies[,]” and that “[t]he issue is whether the expert bridged the ‘analytical gap’
between accepted science and his [or her] ultimate conclusions in a particular case.”
Savage, 455 Md. at 160, 166 A.3d at 195-96.
-6-
In a concurring opinion, the Honorable Sally D. Adkins stated that this Court should
adopt the Daubert approach to the admissibility of scientific testimony. See id. at 174, 166
A.3d at 204 (Adkins, J., concurring). Judge Adkins stated that, “[s]ince Daubert was
decided, the majority of states have departed from the Frye standard in favor of the
Supreme Court’s more flexible approach.” Id. at 178, 166 A.3d at 206 (Adkins, J.,
concurring) (cleaned up). Judge Adkins posited that our recent case law illustrated that the
Court has modified its application of Frye-Reed and gradually moved toward the federal
Daubert approach. Id. at 180, 166 A.3d at 208 (Adkins, J., concurring).
Judge Adkins identified two ways in which she saw that the Court had adjusted the
application of Frye-Reed. First, “we have liberally applied the Frye-Reed analysis to
testimony based on any scientific principle—new or old[,]” thereby, “like Daubert, []
implicitly recogniz[ing] that a trial judge’s gatekeeping function should not be limited to
new scientific theories—old ‘junk science’ should be kept out of our courts as well.” Id.
at 180, 166 A.3d at 208 (Adkins, J., concurring). According to Judge Adkins, we
“suggested that all testimony based on scientific techniques is subject to Frye-Reed by
encouraging trial courts to take judicial notice when a scientific method is well-established
in the relevant community, rather than skipping Frye-Reed because the method is not
novel.” Id. at 180, 166 A.3d at 208 (Adkins, J., concurring) (cleaned up). And, second, in
Judge Adkins’s view, we had “modified the reach of Frye-Reed—inching closer to the
federal Daubert standard—by using it not only to evaluate scientific methods, but also to
assess scientific conclusions.” Id. at 181, 166 A.3d at 209 (Adkins, J., concurring). Judge
Adkins stated that “[t]he federal courts’ adoption of Daubert, coupled with our own
-7-
jurisprudential drift towards the Daubert standard, support departure from Frye-Reed.” Id.
at 187, 166 A.3d at 212 (Adkins, J., concurring). Thus, in deciding Savage, Judge Adkins
would have “do[ne] away with Frye-Reed and h[e]ld that the Daubert factors used to
interpret [Federal Rule of Evidence] 702 are persuasive in interpreting [Maryland] Rule 5-
702.” Id. at 186, 166 A.3d at 211 (Adkins, J., concurring) (footnote omitted).
In her concurring opinion, Judge Akins explained that Stevenson I was not the
appropriate case in which to address a potential adoption of the Daubert standard. As
quoted by the Majority, Judge Adkins stated:
Furthermore, unlike [Stevenson I], our most recent case addressing the
admissibility of scientific expert testimony, we can only dispose of the case
at hand by applying Frye-Reed. In [Stevenson I], we declined to address the
parties’ arguments regarding Frye-Reed and instead held that the expert
testimony was inadmissible under Rule 5-702 because the petitioner had
appealed the trial court’s determination as to both standards. Here, Savage
only challenges the exclusion of [the expert’s] testimony under Frye-Reed.
Maj. Slip Op. at 22 (quoting Savage, 455 Md. at 175 n.1, 166 A.3d at 204 n.1 (Adkins, J.,
concurring)) (alterations in original).
The following year, in Sissoko v. State, 236 Md. App. 676, 707-08, 182 A.3d 874,
892, cert. denied, 460 Md. 1, 188 A.3d 917 (2018), the Court of Special Appeals discussed
Judge Adkins’s concurring opinion, agreeing that Maryland jurisprudence was drifting
toward the Daubert standard. The Court of Special Appeals stated that there had been a
“drift toward applying Frye-Reed to scientific conclusions, not just techniques[,]” thereby
expanding Frye-Reed. Id. at 708, 182 A.3d at 893.
To be sure, the evolution of case law applying and discussing Frye-Reed has led to
discussion in the legal community that Maryland is moving away from Frye-Reed and
-8-
toward Daubert. For example, in two articles published in The Daily Record, one after
Stevenson I was issued and another after Savage was issued, Ronald D. Getchey, Esq., and
Charles A. Danaher, Esq., who are attorneys on brief for Rochkind in this case, discuss
whether there would be a change from Frye-Reed to Daubert in Maryland. See Ronald D.
Getchey and Charles A. Danaher, “Stevenson v. Rochkind: Out of the Frye-ing pan,” The
Daily Record, July 26, 2017; Ronald D. Getchey and Charles A. Danaher, “Why Frye-
Reed appears to be on life support in Md.,” The Daily Record, Aug. 14, 2017. In two
separate posts on the Maryland Appellate Blog,1 one after Savage was issued and another
after Sissoko was issued, Derek Stikeleather, Esq., who is an attorney on brief for Rochkind
in this case, speculated that Frye-Reed was coming to an end in Maryland. See Derek
Stikeleather, “The End of Frye-Reed,” Maryland Appellate Blog, Oct. 5, 2017, available
at https://mdappblog.com/2017/10/05/the-end-of-frye-reed/ [https://perma.cc/62YQ-
K7BV]; Derek Stikeleather, “Update: The End of Frye-Reed Draws Closer,” Maryland
Appellate Blog, May 1, 2018, available at https://mdappblog.com/2018/05/01/update-the-
end-of-frye-reed-draws-closer/ [https://perma.cc/YC5U-JQD2].
From my perspective, regardless of whether Maryland jurisprudence on Frye-Reed
has evolved over the years, there is no need to pick a side between Frye-Reed and Daubert,
and certainly not in this case. Although Rochkind invites the Court to adopt the Daubert
standard, I would decline the invitation. This case is the result of several trials in which
the circuit court did not conduct either a Maryland Rule 5-702 or Frye-Reed hearing. When
1
Maryland Appellate Blog is the blog of the Maryland State Bar Association’s
Litigation Section.
-9-
the case was previously before us, in Stevenson I, 454 Md. at 295-96, 164 A.3d at 265, we
held that Dr. Hall-Carrington’s testimony lacked a sufficient factual basis as required by
Maryland Rule 5-702(3) and remanded the case to the circuit court for a new trial on
damages, with specific instructions concerning the admissibility of Dr. Hall-Carrington’s
testimony on causation. On remand, at trial, the circuit court again admitted Dr. Hall-
Carrington’s testimony. For this Court to now overhaul the standard by which expert
testimony in Maryland is admitted at trial, i.e., the standard by which Dr Hall- Carrington’s
testimony is to be evaluated, and remand the case again, after the circuit court admitted Dr.
Hall-Carrington’s testimony in this case on remand after receiving specific instructions
from this Court, would undermine the finality and predictability of the court system. The
unique procedural process of this case precludes the Court from adopting a new standard
today to be applied in the case. Like Judge Adkins, I would conclude that this case differs
from Savage in that in Savage “we [could] only dispose of the case at hand by applying
Frye-Reed[,]” Savage, 455 Md. at 175 n.1, 16 A.3d at 204 n.1 (Adkins, J., concurring), and
here the admissibility of Dr. Hall-Carrington’s testimony was addressed under Maryland
Rule 5-702, making this not a case in which this Court should entertain a discussion of
adopting the Daubert standard let alone actually implementing such a change.
Although Rochkind relies on the District of Columbia’s adoption of Daubert in
Motorola Inc. v. Murray, 147 A.3d 751 (D.C. 2016), and Judge Adkins’s concurring
opinion in Savage, 455 Md. 138, 166 A.3d 183, the procedural posture of this case is unlike
the posture of both the Motorola and Savage cases, and different even from most cases
adopting Daubert. Moreover, this Court was well aware of the District of Columbia’s
- 10 -
adoption of the Daubert standard, in 2016, in Motorola when, in 2017, we declined to do
the same in Savage. In Motorola, 147 A.3d at 752, the trial court held four weeks of
evidentiary Frye hearings to determine the admissibility of the plaintiffs’ causation expert
testimony. The trial court concluded that some of the expert testimony on causation would
be admissible under Frye, but that “most, if not all” of the testimony would be excluded
under Federal Rule of Evidence 702 and the Daubert standard. Id. The trial court certified
the Daubert adoption question of law for interlocutory appeal. Id. And, the District of
Columbia Court of Appeals granted a motion for interlocutory review, and adopted Federal
Rule of Evidence 702, i.e., Daubert. Id. at 758-59. Unlike Maryland, the District of
Columbia does not have its own codified rules of evidence and, therefore, does not have
its own version of Rule 702. This is different than the situation in Maryland, in which we
have Maryland Rule 5-702, which provides for an analysis that is separate from Frye-Reed
and its progeny’s requisites for admission of expert testimony. Moreover, unlike the
District of Columbia Court of Appeals case, this matter is not before us with a record of
voluminous evidence weighing in favor of or against the differing standards for admission
of expert evidence. In this case, the circuit court never considered or weighed admission
of expert testimony under Frye-Reed or Daubert.
Likewise, unlike this case, in Savage, 455 Md. at 143-50, 166 A.3d at 186-90, the
trial court held an extensive pre-trial evidentiary hearing and determined that the Frye-
Reed standard had not been met. On review, this Court agreed and expressly concluded
that there was no reason to abandon the Frye-Reed standard. In a concurring opinion,
however, Judge Adkins wrote that she was “persuaded in part” by the Motorola decision
- 11 -
that this Court should adopt Daubert. Savage, 455 Md. at 185, 166 A.3d at 211 (Adkins,
J., concurring). Judge Adkins’s discussion was obviously not the holding of this Court and
necessarily addressed the circumstances of Savage, which as Judge Adkins acknowledged
involved a different posture from Stevenson I, and this case.
In contrast to Motorola and Savage, we do not have extensive evidence gathered
from a pre-trial Frye-Reed hearing. As we observed in Savage, 455 Md. at 160 n.6, 166
A.3d at 196 n.6, in Stevenson I, 454 Md. 277, 164 A.3d 254, because we determined that
the circuit court abused its discretion under Maryland Rule 5-702 in admitting the expert
testimony, we did not address the issue of whether the trial court erred in not holding a
Frye-Reed hearing. We now face a case even further attenuated from Stevenson I, because,
on remand, again the circuit court did not hold a Frye-Reed hearing and instead acted
pursuant to specific instructions from this Court pertaining to the admission of the expert
testimony, and the instructions did not involve applying Frye-Reed let alone Daubert. I
see no reason to revisit the standard for admissibility of scientific evidence under Frye-
Reed where, here, like the first iteration of this case, disposition of the issues does not
involve applying Frye-Reed or Daubert.
Maryland case law on the admission of expert testimony pertaining to scientific
matters is understandably capable of adaptation and, in my view, as we concluded in
Savage, 455 Md. at 160, 166 A.3d at 195, just three years ago, there is no need for a change.
The only thing that has changed since the Majority’s holding and Judge Adkins’s
concurrence in Savage is that there has been speculation in the legal community about a
potential change from Frye-Reed to Daubert, and four members of the Court are now in
- 12 -
favor of the change. In announcing the decision to adopt the Daubert standard, the Majority
simply states that “Rochkind now squarely poses th[e] question” and “we answer . . . in the
affirmative[.]” Maj. Slip Op. at 2. Clearly, neither of the circumstances that would warrant
a departure from the doctrine of stare decisis—a prior decision is clearly wrong and
contrary to established principles or existing precedent has been superseded by significant
changes in the law or facts—applies here. See Conover v. Conover, 450 Md. 51, 66, 146
A.3d 433, 442 (2016); DRD Pool Serv., Inc. v. Freed, 416 Md. 46, 64, 5 A.3d 45, 55-56
(2010). Since the Majority’s holding in Savage, there has been no new case law from this
Court indicating that our majority holding was wrong and there have been no further
developments in the law since Savage leading Maryland case law any closer to adoption of
the Daubert standard. Indeed, the Majority’s discussion of the principle of stare decisis
relies entirely on information that was available to Court at the time we issued Stevenson
I and Savage. In an attempt to justify that the exceptions to the doctrine of stare decisis
are met, the Majority states only:
Over the last forty years, Maryland’s appellate courts have considerably
modified the Frye-Reed standard. The Frye-Reed of 1978 is markedly
different than the “Frye-Reed Plus” of 2020. With Daubert, and eventually
Joiner and Kumho Tire, the Supreme Court disavowed the Frye standard for
the more flexible Daubert approach. A supermajority of our sister
jurisdictions followed suit. Clearly, a significant change in the law has
occurred, permitting us to depart from stare decisis and adopt the Daubert
standard in this instance.
Majority Slip. Op. at 28 (footnote omitted). The Majority does not claim that this Court’s
prior adoption of the Frye-Reed standard was clearly wrong, or allege or even mention any
developments subsequent to this Court’s decisions in Stevenson I and Savage that would
- 13 -
warrant a departure from existing case law.
Equally as important, though, as Judge Adkins recognized in Savage, this case is
plainly not the case in which to entertain making a change from Frye-Reed to Daubert, as
the issue of the admissibility of Dr. Hall-Carrington’s testimony has consistently been
decided under Maryland Rule 5-702, not under Frye-Reed. It is undisputed that, on
remand, in admitting Dr. Hall-Carrington’s testimony, the circuit court did not conduct a
Frye-Reed evidentiary hearing and the circuit court did not make any findings under Frye-
Reed, such as whether a novel scientific method was involved and whether that method
was generally accepted within the relevant scientific community. Indeed, Rochkind’s
counsel explicitly agreed with the circuit court that a Frye-Reed hearing was not
appropriate under the circumstances and affirmatively stated that “the appropriate forum
[was] a [Maryland Rule] 5-702 hearing.” The circuit court confirmed, asking: “[Y]ou’re
not asking for the Frye-Reed because you believe that under these circumstances it’s a 5-
702, correct?” Rochkind’s counsel answered: “Correct.”2 In other words, in the circuit
2
This is the exchange that occurred between the circuit court and Rochkind’s
counsel:
[CIRCUIT COURT:] So for those reasons, Defense Counsel was seeking a
5-702, I’m sorry, seeking at this stage a Frye-Reed hearing. And counsel
may not want to freely acknowledge it but, candidly speaking, you do --
you’re going to go with me on this one, that a Frye-Reed hearing is not
appropriate under these circumstances. You’re going to give me that one,
aren’t you?
[ROCHKIND’S COUNSEL]: I do think that the appropriate forum is a 5-
702 hearing.
- 14 -
court, it was clear that case was decided under Maryland Rule 5-702, not under Frye-Reed
and certainly not Daubert.3
[CIRCUIT COURT]: See. This is why I like you. Honesty always helps.
So again, so the issue for the Appellate Courts were to decide that you’re not
asking for the Frye-Reed because you believe that under these circumstances
it’s a 5-702, correct?
[ROCHKIND’S COUNSEL]: Correct.
3
In adopting the Daubert standard, the Majority attempts to rewrite history and
minimize the consequence of Rochkind’s counsel’s agreement that neither a hearing under
Frye-Reed nor Maryland Rule 5-702 was necessary. See Maj. Slip Op. at 26 n.13. It is
beyond dispute that Rochkind’s counsel specifically agreed that a Frye-Reed hearing was
not necessary. Even the Majority acknowledges this, i.e., that Rochkind’s counsel agreed
that a Frye-Reed hearing was not necessary. Yet, the Majority takes the misguided path of
finding significance in the circumstance that, prior to agreeing that a Frye-Reed hearing
was not necessary, “Rochkind’s counsel filed a motion and argued several times at the
motions hearing that a Frye-Reed hearing was needed” and only later made the concession.
Maj. Slip Op. at 26 n.13. The Majority’s statement implies that Rochkind’s counsel’s
concession is meaningless. Under the Majority’s theory, once a party takes a position in
litigation, a court should not consider a concession even if it is made in open court on the
record and there is no dispute that the concession has been made.
In a desperate attempt to counter a simple fact that is plain from the record, the
Majority refuses to recognize that there was an agreement between the parties and the
circuit court that no hearing was necessary. The Majority makes the unfortunate and
inaccurate allegation that “[a] ‘Frye-Reed hearing was not appropriate’ only because the
circuit said so[.]” Maj. Slip Op. at 26-27 n.13. The circuit court judge who presided in
this case is an experienced trial judge with a sterling reputation. The Majority’s allegation
ignores the record and the circumstance that, after having made the request for one,
Rochkind’s counsel readily agreed not to pursue a Frye-Reed hearing.
Similarly, the Majority’s suggestion that, because the Court granted certiorari, this
case is the appropriate vehicle to announce a change to the Daubert standard is flawed. See
Maj. Slip Op. at 26 n.13. The grant of a petition for a writ of certiorari where the petition
contains a particular question is not a guarantee that the Court will necessarily address the
question, let alone that the Court will answer the question by making a sweeping change
in the law. See, e.g., Duffy v. CBS Corp., 458 Md. 206, 217 & n.9, 182 A.3d 166, 172 &
n.9 (2018) (This Court stated that because we answered the first of three questions
presented in a petition for a writ of certiorari in the affirmative and held that the statute of
repose did not apply in that case, we did “not address the remaining questions[,]” including
- 15 -
Put plainly, it is obvious that the issue of the admissibility of Dr. Hall-Carrington’s
testimony, throughout the many trials in this case, has been considered only under
Maryland Rule 5-702, that Rochkind expressly agreed that the matter should be considered
under Maryland Rule 5-702 and that a Frye-Reed hearing was not appropriate under the
whether the Court of Special Appeals’s decision violated a person’s “constitutional right
to access the courts[.]”); State v. Weems, 429 Md. 329, 332, 55 A.3d 921, 925 (2012) (This
Court granted a petition for a writ of certiorari raising two questions, but did not address
the second question because we affirmed the Court of Special Appeals’s judgment and
answered the first question in the negative.); Prof’l Staff Nurses Ass’n v. Dimensions
Health Corp., 346 Md. 132, 133-34, 138, 141-42, 695 A.2d 158, 158, 160, 162-63 (1997)
(This Court granted a petition for a writ of certiorari raising only a single constitutional
issue—whether the National Labor Relations Act preempted the Maryland anti-
strikebreakers statute—but “conclude[d] that the constitutional issue should not have been
reached” and affirmed the Court of Special Appeals’s judgment on a non-constitutional
ground.); see also Stevenson I, 454 Md. at 284-85, 295, 164 A.3d at 258, 265 (This Court
granted certiorari on two issues—whether the circuit court erred in admitting Dr. Hall-
Carrington’s generally and specific ADHD causation testimony under Maryland Rule 5-
702 and whether the circuit court erred in failing to hold a Frye-Reed hearing on Dr. Hall-
Carrington’s general ADHD causation testimony—and did not reach the issue concerning
the Frye-Reed hearing given our resolution of the matter under Maryland Rule 5-702.).
In addition, case law recognizes that the Court may dismiss a petition for a writ of
certiorari for being improvidently granted. See, e.g., Sturdivant v. Md. Dep’t of Health
and Mental Hygiene, 436 Md. 584, 589, 84 A.3d 83, 86 (2014) (“On occasion, this Court
dismisses a case after briefing and argument on the ground that the petition for writ of
certiorari was improvidently granted. In such cases the grant of the petition was a mistake,
either because it becomes apparent later that there is truly no issue of public importance in
the case or because there is such an issue, but it was not preserved below or the record in
the case provides an inadequate basis for rendering useful guidance on that issue.”); see
also McFarland v. Baltimore Cmty. Lending, Inc., 467 Md. 428, 429, 225 A.3d 83, 83
(2020) (This Court dismissed a petition for a writ of certiorari as “having been
improvidently granted.”). Also, Maryland Rule 8-604(d)(1) allows the Court to not affirm,
reverse, or modify a judgment, but instead to remand so “that justice will be served[.]” In
stating that this Court granted certiorari to answer the very question of whether to adopt
Daubert, the Majority ignores these well-known appellate principles. Moreover, the
Majority wrongly implies that the Court did not have the option of concluding that this was
not an appropriate case in which to consider adopting the Daubert standard.
- 16 -
circumstances, and that no findings were made under Frye-Reed in the circuit court. Stated
otherwise, under the circumstances of this case, the Court has no basis on which to
conclude that the Frye-Reed analysis should be abandoned in favor of the Daubert analysis.
This Court should refrain from deciding a matter not at issue in the circuit court and making
a decision not warranted by the circumstances of the case. In my view, under no
circumstance should we switch from Frye-Reed to Daubert, in a case in which no issue
pertaining to either approach was decided by the circuit court—and the case is back before
this Court after a remand that did not involve instructions from the Court pertaining to
Frye-Reed or Daubert—simply because one party now seizes the opportunity to pose the
question of whether this Court should adopt the Daubert standard.
Even if the issue of whether to abandon the Frye-Reed standard and adopt the
Daubert standard were squarely before the Court, i.e., the circuit court had made findings
under Frye-Reed or one of the parties had argued the issue in the circuit court, from my
perspective, adoption of the Daubert standard should not be done without information
about the impact that adopting Daubert would have on African American people, people
of color, and people of various socioeconomic status in Maryland. In a brief of amicus
curiae filed in this case, the Maryland Association for Justice indicates that the Daubert
standard has resulted in some plaintiffs not being able to effectively present expert witness
testimony. The Maryland Association for Justice points to studies by professors
demonstrating that application of the Daubert standard “disproportionately and negatively
affects claimants of color.” Andrew W. Jurs and Scott DeVito, A Tale of Two Dauberts:
Discriminatory Effects of Scientific Reliability Screening, 79 Ohio St. L.J. 1107, 1144
- 17 -
(2018). The professors’ analysis demonstrated that “Daubert [has] resulted in fewer claims
by black claimants, and that once the claimants are out of the system, they stay out.” Id. at
1144-45. This analysis concerning the impact of Daubert is extremely troubling. At a
minimum, before any decision to adopt the Daubert standard, I would recommend that the
Standing Committee on Rules of Practice and Procedure undertake a study of the impact
of Daubert and make a determination as to whether adoption of Daubert in Maryland will
negatively affect African American people, people of color, or people of limited financial
means as potential litigants.
Wisely, the majority opinion does not “reject the seriousness of th[e] contention”
that the “Rules Committee is the more appropriate forum to study the potential impact the
Daubert standard” would have in Maryland. Maj. Slip Op. at 28-29 n.15. But, the
Majority summarily disposes of the suggestion by alleging that other scholarly research
has come to “the opposition conclusion.” See Maj. Slip Op. at 29 n.15. The Majority
identifies only one such source, and by its’ own admission, there is disagreement as to the
impact of the Daubert standard. Yet, the Majority is willing to implement that standard in
our State without study. Unfortunately, rather than refer the matter to the Rules
Committee, the Majority states that, “[t]his Court is well suited to weigh the advantages
and disadvantages of modifying our approach to any area of the law—as we often do. That
this change implicates our interpretation of the Maryland Rules does not necessitate a
referral to the Rules Committee.” Maj. Slip Op. at 29 n.15. With this language, the
Majority attempts to equate the change from the Frye-Reed standard to the adoption of the
Daubert standard in Maryland to a mere interpretation of the Maryland Rules and not the
- 18 -
significant change—that reads into Maryland Rule 5-702 a new evidentiary standard that
was not previously a part of the Rule—that it is. Other than including a quote in a
parenthetical from a fifteen-year-old article—Edward K. Cheng & Albert H. Yoon, Does
Frye or Daubert Matter? A Study of Scientific Admissibility Standards, 91 Va. L. Rev. 471(2005)—the Majority provides no information about the impact of Daubert, does no
weighing about the effects of the switch, and gives no information on how litigants in
Maryland will be impacted.4 The Majority appears to assert that the matter of Daubert’s
4
Indeed, other than the parenthetical, the Majority provides no information about
the article or its purpose, specifically, whether its purpose was to study the impact of
Daubert on specific groups, or whether the article even mentions Maryland. The Majority
does not advise that the article, like other sources, likens Daubert to tort reform, stating:
In federal courts, where the decision is legally binding, Daubert has become
a potent weapon of tort reform by causing judges to scrutinize scientific
evidence more closely. Tort reform efforts often focus on medical
malpractice, products liability, and toxic torts--all cases in which scientific
evidence is likely to play a decisive or at least highly influential role. The
resulting effects of Daubert have been decidedly pro-defendant. In the civil
context, Daubert has empowered defendants to exclude certain types of
scientific evidence, substantially improving their chances of obtaining
summary judgment and thereby avoiding what are perceived to be
unpredictable and often plaintiff-friendly juries.
Edward K. Cheng & Albert H. Yoon, Does Frye or Daubert Matter? A Study of Scientific
Admissibility Standards, 91 Va. L. Rev. 471, 472-73 (2005) (footnote omitted). After
reaching this conclusion, the article purports to review the impact of Daubert in states by
examining developments in specifically identified states that have and have not adopted
the Daubert standard; Maryland is not among the states included in the article. Also, the
article does not purport to study the effect of the Daubert standard on different communities
within those states. As such, although the article purports to evaluate whether “doctrinal
standards have any effect on scientific admissibility determinations” and reaches a general
conclusion that it “found no evidence that Frye or Daubert makes a difference,” id. at 510-
11, in addition to being fifteen years old, the article reaches no conclusions whatsoever
about the impact of the Daubert standard not having been adopted in Maryland or any
- 19 -
potential impact of this Court adopting the standard now. The article also does not address
the issue that the Maryland Association for Justice raises in its amicus brief concerning a
potential disparate impact of Daubert on various communities in the State.
In contrast, the more recent Andrew W. Jurs & Scott DeVito law review article
addresses Daubert’s disproportionate impact on African American plaintiffs and claimants
of color, stating:
We found that when the federal system adopted the stricter standard
of Daubert in 1993, there was a disproportionate and negative impact on
filings from African-American plaintiffs along with a corresponding rise in
filings from white plaintiffs. Yet that is not all we found. In prior work, we
found that when a state adopted Daubert after 1993, there was a “return to
federal court” effect where filings rebound to pre-1993 patterns. Yet our
analysis reveals that after state adoption of Daubert, there is no rebound for
African-American plaintiffs; instead, the filing rates for black plaintiffs
remain depressed.
Our research shows that, in response to Daubert, black plaintiffs were
less likely to file in federal court, and once they were pushed out of the civil
justice system, they remained out. In essence, the Daubert admissibility
standard impacts filings exactly like a method of tort reform, but only for
claimants of color.
Andrew W. Jurs & Scott DeVito, A Tale of Two Dauberts: Discriminatory Effects of
Scientific Reliability Screening, 79 Ohio St. L.J. 1107, 1109-10 (2018) (footnotes omitted).
Another law review article indicates that Daubert and its progeny may have
“significant gender, race, and class implications,” stating:
[T]rial judges have used [Daubert and its progeny], despite Daubert’s
announced intention to liberalize decisions on admitting scientific expert
causation testimony, to erect conservative, and in some instances, virtually
insurmountable barriers to plaintiffs’ ability to prove causation. These
barriers stem from substantive legal decisions about causation law, rather
than from scientific principles or case by case assessments of proffered
testimony. Finally, the article analyzes some of the societal implications of
these legal developments, including differential impact on social groups
whose health problems have tended to be ignored or underexplored by the
scientific research community[.]
***
- 20 -
There are also likely to be subtle, but significant gender, race, and
class implications of the heightened requirements for proof of
causation. Certain social groups have traditionally drawn greater research
interest and research dollars. For example, medical problems of middle-aged
white men have received a disproportionate amount of research attention,
while the problems of women, the poor, and members of minority racial and
ethnic groups have received less attention. Political groups or other
organizations can also stimulate research attention to potential health
problems--for example, the unions have played an important role in pushing
for research into asbestos and other occupational exposures; veterans groups
have continued to demand better Agent Orange and Gulf War Syndrome
research. Until the relatively recent attention devoted by civil rights groups
to toxic exposure issues in poor minority communities, and the activism of
women’s groups around breast cancer research or [diethylstilbestrol]
research, the advocacy groups that prodded regulatory agencies or the
research community were more likely to represent largely male
constituencies, such as industrial workers. For these reasons, the products,
exposures, and diseases for which there is likely to be well-developed
epidemiologic research will not be gender, race, or class-neutral. The
societal groups most likely to be under-studied by the research community
are often going to be the same groups whose health concerns have received
less initial scrutiny from product or drug manufacturers. If the epidemiologic
community has not produced enough research into some types of the
exposures and risk factors facing women, minorities, and the poor, then these
groups will be inherently disadvantaged when they try to use the tort system
to redress their health problems and to stimulate more serious manufacturer
and researcher attention to their concerns. The long-standing inequities of
medical research can lead to differential race, gender, and class-based access
to the tort system.
Lucinda M. Finley, Guarding the Gate to the Courthouse: How Trial Judges Are Using
Their Evidentiary Screening Role to Remake Tort Causation Rules, 49 DePaul L. Rev. 335,
337-38, 373-74 (1999) (footnotes omitted).
Several sources state that Daubert has the effect of lowering costs for defendants
and raising costs for plaintiffs. See Sandra F. Gavin, Managerial Justice in A Post-Daubert
World: A Reliability Paradigm, 234 F.R.D. 196, 212 (2006) (“Th[e] shift to the pretrial
arena significantly raises the costs and risks for plaintiffs while diminishing the costs and
risks for defendants particularly when Daubert and summary judgment intersect.”);
Richard A. Nagareda, 1938 All over Again? Pretrial As Trial in Complex Litigation, 60
DePaul L. Rev. 647, 669 (2011) (“The further nuance imparted by Daubert and its progeny
is to reduce the cost to the defendant of deploying the summary judgment motion. Under
- 21 -
impact in Maryland is resolved by one article from fifteen years ago that the Majority does
not even contend provides any information about the impact of the implementation of
Daubert in Maryland. The Majority provides no principled reason for declining to refer
the matter to the Rules Committee.
To be sure, the Committee note to Maryland Rule 5-702 states that “[t]he required
scientific foundation for the admission of novel scientific techniques or principles is left to
development through case law.” (Citation omitted). The Committee note was included
with Maryland Rule 5-702, which was adopted on December 15, 1993 and became
effective on July 1, 1994, at the time when the Standing Committee on Rules of Practice
and Procedure undertook to revise the Maryland Rules to be consistent with the Federal
Rules. Daubert was issued on June 28, 1993, see Daubert, 509 U.S. 579, just months before
the adoption of Maryland Rule 5-702. The adoption of Maryland Rule 5-702 and inclusion
this line of cases, the defendant simply may insist that the plaintiff--the party with the
ultimate burden of proof--show her evidentiary cards. A moving defendant need not
affirmatively demonstrate the absence of a genuine issue of material fact.” (Footnote
omitted.)); Sean Ryan, Backfire: Abandoning the Abuse of Discretion Standard of Review
for Daubert Rulings Shoots Trial Courts in the Foot, 47 U. Tol. L. Rev. 349, 368-69 (2016)
(“A 2001 Institute for Civil Justice Study concluded that the extra burden of defending
against Daubert motions had a chilling effect on plaintiffs. The unpredictability caused by
a heightened standard of review of Daubert decisions on appeal will often increase those
costs for plaintiffs.” (Footnote omitted.)); Arthur R. Miller, Simplified Pleading,
Meaningful Days in Court, and Trials on the Merits: Reflections on the Deformation of
Federal Procedure, 88 N.Y.U. L. Rev. 286, 313 (2013) (“Daubert’s high threshold has
been particularly burdensome-- financially, logistically, and sometimes both--for plaintiffs.
This is because plaintiffs often must provide expert testimony or reports about a wide range
of subjects-- for example, the relevant technology, pharmacology, the environmental
impact of the defendant’s conduct, or the statistical and economic significance of certain
phenomena or behaviors.”). Plainly, these articles demonstrate there is an imperative need
to examine the impact of Daubert in Maryland before the wholesale adoption of the
standard.
- 22 -
of the Committee note occurred before the timeframe in which any impact of the Daubert
standard on litigants would have been at issue, and the Committee note obviously predates
by decades Jurs’s and DeVito’s article concerning studies showing the negative impact of
Daubert on some groups. Although the Committee note to Maryland Rule 5-702 could be
read to mean that this Court can adopt the Daubert standard through case law, in my view,
given the weighty issues at stake, there is a need for study of the matter. In addition to the
circumstance that this case is not the appropriate one for entertaining the change, before
deciding whether to adopt the Daubert standard, this Court should have its impact
investigated and the Court should attempt to understand the impact on the community.
The circumstance that there may have been a drift from Frye-Reed to Daubert and
that portions of the Daubert analysis may be already be in place in Maryland case law does
not negate the need for a study of the impact of Daubert on litigants. It should not be said
that because this Court may have already modified the Frye-Reed standard, we should not
investigate any burden that the Daubert standard may impose on Maryland’s citizenry. The
Court should want to ensure that equal access to the court system is provided to all and that
case law is developed in a manner that is consistent with equal access. Information on the
impact of the Daubert standard is information that the courts, the Bar, and the legal
profession in general should be made aware of before this Court determines whether to
take the action of adopting the Daubert standard for use in our State.
Lastly, in this case, I would hold that the circuit court did not abuse its discretion in
admitting Dr. Hall-Carrington’s testimony under Maryland Rule 5-702. This Court has
repeatedly reiterated that “[t]he admissibility of expert testimony is a matter largely within
- 23 -
the discretion of the trial court[; t]hus, we review a trial court’s decision to admit or exclude
expert testimony only for an abuse of discretion.” Rochkind v. Stevenson, 454 Md. 277,
285, 164 A.3d 254, 258-59 (2017) (cleaned up). In Blackwell, 408 Md. at 618, 971 A.2d
at 261, this Court stated:
In the context of Rule 5-702, we have previously stated that, the admissibility
of expert testimony is within the sound discretion of the trial judge and will
not be disturbed on appeal unless clearly erroneous. Put another way, it is
well settled that the trial court’s determination regarding the qualification of
experts may be reversed if it is founded on an error of law or some serious
mistake, or if the trial court clearly abused its discretion and will seldom
constitute a ground for reversal.
(Cleaned up).
Utilizing the principles expressed above, I would conclude that the circuit court did
not abuse its discretion under Maryland Rule 5-702 in admitting Dr. Hall-Carrington’s
testimony and, specifically, the testimony that Stevenson has a physical brain injury
attributable to lead exposure that has manifested in symptoms of inattention, hyperactivity,
impulsivity, and IQ loss. On remand, the circuit court specifically described the procedural
history of the case and that the case had come back from the Court of Appeals with the
Court having concluded that there was an insufficient link, i.e., a gap, between Dr. Hall-
Carrington’s opinion that lead exposure caused ADHD and the data. The circuit court
understood that the issue that was before the court was whether there was a sufficient
factual basis to permit Dr. Hall-Carrington to testify that lead exposure caused attention
deficits, hyperactivity, and cognitive development problems. As Rochkind’s counsel
characterized it, Dr. Hall-Carrington’s proposed testimony involved the ability to render
“specific causation opinions regarding attentional difficulty, things that may lead to or
- 24 -
some of the symptoms of ADHD.” After framing the issue, the circuit court stated, among
things, “[s]o there’s no objection to not having a hearing where there’s live testimony
because all parties are satisfied that what is before the [c]ourt is [t]hat the [c]ourt needs to
make a decision under 5-702-3.” The parties agreed that no hearing, Frye-Reed or
otherwise, was necessary. After hearing extensive argument from the parties as to whether
Dr. Hall-Carrington’s testimony would be admissible under Maryland Rule 5-702(3),
which included references to Dr. Hall-Carrington’s prior trial testimony detailing the
numerous sources of information she reviewed pertaining to Stevenson as well as her
review of the EPA-ISA, and references to the requirements of the Rule, the circuit court
ruled that it was satisfied that Dr. Hall-Carrington’s opinion would assist “the trier of fact
. . . [and that] the trier of fact would be able to evaluate the reasoning underlying that
opinion.” The circuit court ruled that it was “satisfied that the research does show that lead
exposure can cause general attention deficits and hyperactivity[.]” In other words, the
circuit court considered whether there was an analytical gap between Dr. Hall-Carrington’s
data and her opinion and ruled that the testimony satisfied Maryland Rule 5-702(3), as
there was a sufficient factual basis to support the expert’s causation testimony.
The circuit court was correct. There was a sufficient factual basis to support Dr.
Hall-Carrington’s testimony, as there was an adequate supply of data and she provided a
reliable method for attributing Stevenson’s injuries to lead exposure.5 As to an adequate
5
In the circuit court, Rochkind conceded that the only issue was whether Dr. Hall-
Carrington had a sufficient factual basis for her opinions under Maryland Rule 5-702(3).
In other words, Rochkind did not take issue with whether Dr. Hall-Carrington was qualified
- 25 -
supply of data, Dr. Hall-Carrington testified that she reviewed and relied upon numerous
records and documents concerning Stevenson to form the basis for her opinions, including,
among other things,: birth records; records from the Pediatric Ambulatory Center early
childcare clinic of the University of Maryland; records from the Greater Baltimore Medical
Center clinic; records from Mercy Medical Center clinic; records from Kennedy Krieger
Institute; Kennedy Krieger Institute’s social work records; a neuropsychological evaluation
performed by Dr. Thomas Ley; blood-lead records from the Maryland Department of the
Environment; records from Mount Washington Pediatric Hospital; a neuropsychological
evaluation by Dr. William Collins; school records; the evaluation report and trial testimony
of Dr. Robert Kraft; the evaluation report of Stevenson’s psychologist, Dr. Cynthia Munro;
the report of Stevenson’s psychiatrist, Dr. Neil Blumberg; the 2014 trial testimony of
Stevenson’s mother, Charlene Montgomery; and the November 2017 deposition of
Stevenson.
Dr. Hall-Carrington testified that she was familiar with and had read the portion
related to lead contained in the Environmental Protection Agency’s 2013 publication, the
EPA-ISA, which she described as “a review of all the research from around the world and
it’s a peer reviewed articles, but it’s a review of all the research, scientific research that
was available at the time. [The EPA] actually go[es] through hundreds of articles in
forming [] opinions in this document.” Dr. Hall-Carrington testified that she was also
familiar with the underlying studies that the Environmental Protection Agency cited to and
as an expert under Maryland Rule 5-702(1) or the appropriateness of expert testimony on
the particular subject under Maryland Rule 5-702(2).
- 26 -
relied on. Dr. Hall-Carrington testified that she reviewed EPA-ISA findings and there was
documented a “causal relationship” between even low levels of lead exposure, of 2 to 8
micrograms/deciliter (µg/dL), and “Cognitive Function Decrements” with learning,
memory, and executive function. Dr. Hall-Carrington testified that EPA-ISA showed a
“causal relationship” between externalizing behaviors such as attention, impulsivity, and
hyperactivity and lead exposure in children with blood-lead levels between 7 and 14 µg/dL.
Dr. Hall-Carrington also testified that the EPA-ISA concluded that there is a “likely causal
relationship” between internalizing behaviors such as anxiety and depression and lead
exposure in children with blood-lead levels “about 14” µg/dL.
As to reliable methodology, Dr. Hall-Carrington’s opinions were not conclusory or
ipse dixit, “because I said so,” opinions. Dr. Hall-Carrington’s thorough review of the
numerous records related to Stevenson gave her specific and detailed information related
to Stevenson’s medical history, including prior physical examinations and the results of
clinical tests. It is not necessary that an expert witness conduct a physical examination of
a person before being permitted to render an opinion. See Levitas v. Christian, 454 Md.
233, 241, 253-54,164 A.3d 228, 233, 240-41 (2017) (In a lead paint case, this Court held
that a trial court abused its discretion in excluding a plaintiff’s expert’s testimony on the
ground that he had not examined the plaintiff, and had instead relied on a report from
another doctor who had examined the plaintiff.); Sugarman v. Liles, 460 Md. 396, 403-05,
410, 190 A.3d 344, 348-39, 352 (2018) (In a lead paint case, a pediatrician who was an
expert for the plaintiff, as well as a pediatrician who was an expert for the defendant, did
not examine the plaintiff, and instead relied on his medical records, the report of another
- 27 -
doctor who had examined the plaintiff, and other documents.). And, although we indicated
in Sugarman, 460 Md. at 424, 190 A.3d at 360, that the EPA-ISA does not provide clinical
criteria for determining whether an individual has been affected by lead, Dr. Hall-
Carrington did not rely exclusively on the EPA-ISA in rendering her opinion as to
causation concerning Stevenson. It is clear that Dr. Hall-Carrington based her opinion on
numerous sources containing information specific to Stevenson. Dr. Hall-Carrington
conducted a thorough review and analysis of, among other things, various medical records,
neuropsychological evaluations, and other records related to Stevenson, and was capable
of performing a differential analysis through that review. This analysis led Dr. Hall-
Carrington to render an opinion to a reasonable degree of medical probability that lead
exposure was a substantial contributing factor in causing Stevenson’s brain impairments
that manifested in an IQ loss of five to six points, a learning disability, and neurocognitive
behavioral effects including hyperactivity, impulsivity, and attention decrements. It is
clear that Dr. Hall-Carrington did not simply apply the conclusions of the EPA-ISA to
Stevenson’s case without analysis of medical and other information pertaining to
Stevenson, but instead relied upon a plethora of records and reports specifically related to
Stevenson as well as her own training, experience, and expertise in treating children with
lead poisoning, to render her opinion. In my view, Dr. Hall-Carrington’s testimony at trial
more than satisfied the requirements of Maryland Rule 5-702(3), and specifically satisfied
the Rule’s requirement that expert testimony be supported by a sufficient factual basis,
including an adequate supply of data and a reliable methodology.
I disagree with the Majority’s conclusion that the circuit court abused its discretion
- 28 -
in admitting Dr. Hall-Carrington’s testimony. See Maj. Slip Op. at 25-26. The Majority’s
analysis on this point departs from the record and is wrong on this point in multiple ways.
The Majority states that, in admitting Dr. Hall-Carrington’s testimony, the circuit court
relied solely on Stevenson I and the Majority implies that the circuit court found that in
Stevenson I this Court concluded that the EPA-ISA required a finding that lead specifically
caused Stevenson’s injuries. See Maj. Slip Op. at 25. Contrary to the Majority’s
assessment, the circuit court did not find based on Stevenson I that the EPA-ISA mandated
a finding that lead specifically caused Stevenson’s attention decrements, hyperactivity, and
impulsivity. See Maj. Slip Op. at 25. Rather, the record reflects that the circuit court
correctly understood that, in Stevenson I, 454 Md. at 293-96, 164 A.3d at 263-65, this
Court held that there had been no check for an analytical gap between Dr. Hall-Carrington’s
data and her opinion that lead exposure can cause ADHD, and thus Dr. Hall-Carrington’s
testimony concerning ADHD was inadmissible. Contrary to the Majority’s assertion, the
circuit court did not find that Dr. Hall-Carrington’s testimony about attention deficits and
hyperactivity would be automatically admissible based on this Court’s holding in
Stevenson I. The record reflects that the circuit court understood that this Court did not
direct that Dr. Hall-Carrington’s testimony would be admissible on that point, but instead
that Stevenson was required to demonstrate a sufficient factual basis for Dr. Hall-
Carrington’s opinion that exposure to lead was a substantial factor in causing Stevenson’s
injuries, i.e., attention deficits and the like. The circuit court stated: “So this [c]ourt is here
at this stage at this initial stage to determine whether or not the testimony of Dr. . . . Hall-
Carrington will be appropriate.” Referring to this Court’s opinion in Stevenson I, the
- 29 -
circuit court stated that “[i]t says that you can’t use the word ‘ADHD’ which is a diagnosis,
but it clearly shows that those symptoms that you referred to are caused by lead or that
there are studies to show that it’s caused by lead.” The circuit court recognized, however,
that Stevenson was required to demonstrate that Dr. Hall-Carrington’s testimony
concerning attention deficits and hyperactivity was admissible under Maryland Rule 5-702.
The circuit court stated: “I’m also clear that that case says that under the right
circumstances there can be an opinion based on what has been presented to show that there
are certain disorders and certain deficits.” Ultimately, as explained above, the circuit court
concluded that the jury (trier of fact) would be able to evaluate the reasoning underlying
Dr. Hall-Carrington’s opinion and that the circuit court was satisfied that the data (research)
showed that lead exposure could cause attention deficits and hyperactivity. The record
simply does not support a conclusion that the circuit court found Dr. Hall-Carrington’s
testimony to be admissible “so long as she did not use the term ‘ADHD.’” Maj. Slip Op.
at 25.
Just as troubling, in reaching a decision that a remand is necessary, the Majority
concludes that the circuit court erred in refusing to hold a Maryland Rule 5-702 hearing, at
which Dr. Hall-Carrington could explain and Rochkind could cross-examine regarding
specific causation methodology. See Maj. Slip Op. at 25. Once again, the Majority is
incorrect. The record reveals that the parties agreed that the circuit court need not hold a
Maryland Rule 5-702 hearing and that the parties agreed that the transcript of Dr. Hall-
Carrington’s testimony from the trial that had occurred previously (the trial underlying
Stevenson I), along with proffers by the attorneys, would be the agreed-upon manner to
- 30 -
proceed. As explained above, both parties agreed (i.e., Rochkind had conceded) that a
Frye-Reed hearing was not the manner in which to proceed and that the issue was properly
resolved under Rule 5-702. After that, the following colloquy occurred:
THE COURT: I wanted to make sure before I rule. All right. So with that,
the [c]ourt did believe that it would be appropriate to either have a full
hearing where the Defendants would be able to present the witnesses. The
burden would be on the Plaintiff. The Plaintiff would be able to offer Dr.
Cecilia Hall-Carrington.
The parties have agreed based on conversations with the [c]ourt that
the testimony of Cecilia Hall- Carrington which is before the Court that was
in front of [a different circuit court j]udge [] will be similarly presented to
this jury.
***
Again, so there’s no objection to not having a hearing where there’s live
testimony because all parties are satisfied that what is before the [c]ourt is
what the [c]ourt needs to make a decision under 5-702-3. Correct, Defense?
[ROCHKIND’S COUNSEL]: Yes, Your Honor, that’s correct.
THE COURT: And correct, Plaintiff?
[STEVENSON’S COUNSEL]: Yes, Your Honor.
THE COURT: All right. I will now hear from Plaintiff.
The Majority misunderstands what occurred in the circuit court. The circuit court
initially denied Rochkind’s motion to exclude Dr. Hall-Carrington’s testimony in its
entirety. The circuit court found that, under Stevenson I, Dr. Hall-Carrington could be
permitted to testify under certain circumstances. The circuit court stated: “I’m also clear
that that case says that under the right circumstances there can be an opinion based on what
has been presented to show that there are certain disorders and certain deficits. And we
may get to that at some point.” After this ruling, Rochkind filed a request to brief for a
- 31 -
Rule 5-702/Frye-Reed hearing, seeking to limit Dr. Hall-Carrington’s ability to testify
under any circumstances about the symptoms of attention deficits and hyperactivity. The
next day, as the circuit court addressed the additional filing, the parties agreed on the record
(as explained above) that the matter should be resolved under Rule 5-702 (not Frye-Reed)
and then agreed that a Rule 5-702 hearing was not necessary. The circuit court considered
argument from counsel, discussed the circumstances of the case, including this Court’s
holding in Stevenson I, and found that there was no analytical gap between the data and
Dr. Hall-Carrington’s opinion. It is impossible to conclude, as the Majority does, that the
circuit court erred or abused its discretion by not holding a Rule 5-702 hearing when the
record unequivocally demonstrates that the parties agreed that no hearing was necessary
and the circuit court outlined in detail on the record that agreement.
Yet, after wrongfully concluding that the circuit court abused its discretion, the
Majority remands for the circuit court to conduct a hearing pursuant to Maryland Rule 5-
702 (which the parties agreed was unnecessary); the Majority states that “the circuit court
should consider the Daubert standard adopted herein.” Maj. Slip Op. at 26. It is clear that
the remand to the circuit court to conduct a Maryland Rule 5-702 hearing is nothing more
than the Majority’s way to shoehorn in justification for adopting the Daubert standard.
Apparently determined to implement Daubert in Maryland by any means necessary, the
Majority is willing to disregard an on-the-record concession that the issue involving the
admissibility of Dr. Hall-Carrington’s testimony was not to be resolved under Frye-Reed,
an agreement by the parties that no hearing was necessary under Maryland Rule 5-702, and
that neither of the exceptions to the doctrine of stare decisis is applicable, and the Majority
- 32 -
is willing to refuse to refer the matter to the Rules Committee for study of how the decision
will impact Marylanders when there are numerous scholarly sources indicating that the
adoption of Daubert has far-reaching consequences. These are not the circumstances under
which this Court should implement such a significant change in the use of Maryland Rule
5-702 and such an important development in case law in our State.6
For the above reasons, respectfully, I dissent.
Judge Hotten and Judge Greene have authorized me to state that they join in this
opinion.
6
Finally, the Majority states: “Since Daubert is a new interpretation of Rule 5-702,
our decision today applies to this case and any other cases that are pending on direct appeal
when this opinion is filed, where the relevant question has been preserved for appellate
review.” Maj. Slip Op. at 39 (cleaned up). In Griffith v. Kentucky, 479 U.S. 314, 322
(1987), the Supreme Court held that not applying a newly announced constitutional rule to
criminal cases pending on direct appeal is not consistent with basic principles of
constitutional adjudication. In light of the Supreme Court’s holding in Griffith, in some
instances, this Court has given the application of new holdings to cases that were pending
on appeal, where the new holding involved an issue of constitutional significance in
criminal law. See, e.g., Hackney v. State, 459 Md. 108, 119, 184 A.3d 414, 421 (2018);
State v. Daughtry, 419 Md. 35, 77 n.26, 18 A.3d 60, 85 n.26 (2011). Neither the holding
in Griffith concerning the application of a newly announced constitutional rule nor the
application of Griffith in Kazadi v. State, 467 Md. 1, 47, 223 A.3d 554, 581 (2020), and
Daughtry would apply to a change of the evidentiary standard for use under Maryland Rule
5-702. Here, the Majority’s holding should apply to this case and future trials; the
Majority’s opinion should not be construed as giving rise to any grounds for relief in cases
in which the trial occurred before the issuance of this opinion.
- 33 -